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Utilization of patient-specific stem cells in regenerative medicine provides a novel 
treatment approach for diseases and disorders.  Embryonic stem cells and induced pluripotent 
stem cells can differentiate into any cells found within the body; however, ethical, technical and 
safety concerns have to be overcome before they can be used in clinics.  Patient-specific stem 
cells can be isolated from adult tissues with no ethical, fewer technical, and safety concerns.  
Obtaining tissues for stem cell isolation usually requires invasive procedures, but impacted teeth 
are often extracted in the clinics and can be used for isolation of dental follicle stem cells 
(DFSCs).   
The overall goal of this dissertation is to characterize the osteogenic potential of DFSCs 
and to explore the possibility of using DFSCs for the treatment of craniofacial defects. In this 
regard, we first showed that DFSCs can be induced to differentiate primarily toward the 
osteoblast lineage.  Our experiments showed that DFSCs at passages 3 to 5 have a strong 
osteogenic capability that is reduced during in vitro expansion.  Comparing DFSCs with non-
stem cell dental follicle cells (DFCs), we determined that dentin matrix protein 1 (DMP1) is 
highly expressed in DFSCs. Further study suggests that DMP1 is likely necessary to maintain the 
osteogenic differentiation capability of DFSCs via regulating expression of osteogenic genes. 
Given that adult stem cells exist in a quiescent state under normal physiological conditions, we 
attempted to activate DFSCs with heat-stress. Culturing DFSCs under mild heat-stress (39ºC-
40ºC) could effectively promote their proliferation and osteogenic differentiation. In the final 
part of this project, in vivo transplantation experiments were conducted to evaluate the 
osteogenic potential of DFSCs for treatment of calvarial critical-size defects using a rat model. 
Bone regeneration was assessed by micro-computed tomography (micro-CT) and histological 
xii 
 
analysis at 4 and 8 weeks post-transplantation. The results showed that transplantation of DFSCs 
seeded into PCL scaffold significantly improved bone regeneration. An average of 50% bone 
recovery was observed with treatment of PCL-DFSC transplantation at 8 weeks. In conclusion, 
this study found that DFSCs are valuable tissue stem cells possessing strong osteogenic potential 
that can be used for repairing craniofacial defects.  
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CHAPTER 1: STEM CELLS AND DENTAL FOLLICLE STEM 
CELLS IN REGENERATIVE MEDICINE  
 
1.1 OVERVIEW 
One of the most fascinating areas in regenerative medicine is the utilization of 
stem cells for regeneration of damaged tissues or replacement of diseased organs. 
Although embryonic stem cells (ESCs) are pluripotent and can differentiate into any 
cell types found within the body, use of ESCs raises various issues including safety and 
ethical concerns [1-3]. Induced pluripotent stem cells (iPSCs) also have been reported 
[4, 5].  They can be produced by reprogramming patients´ own somatic cells into 
patient-specific stem cells that can be used for autogenous transplantation.  However, 
tumorigenicity after transplantation of ESCs and iPSCs is the major threat in human 
therapies.  Such tumorigenicity is likely due to their pluripotency [6].  Currently, it is 
not clear whether the obstacles to use of ESCs and iPSCs for human treatment can be 
overcome.  
Stem cells also can be isolated from adult tissues.  Due to lack of 
tumorigenicity after transplantation [7], they are considered safe for human therapies. 
Tissue-derived adult stem cells are multipotent and can differentiate into limited types 
of cells, within the same germ layer of tissues in which they reside. Our lab, as well as 
others, reported the isolation of dental follicle stem cells (DFSCs), with multipotent 
differentiation capabilities [8-10].  
This dissertation aims to further characterize the DFSCs in Chapters 2-4. 
Moreover, in Chapter 5, we explored the possibility of the utilization of DFSCs for 
repair of craniofacial defects using rats as experimental animals. This dissertation 
provides important information toward the clinical applications of DFSCs.         
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1.2 STEM CELLS 
Stem cells are clonogenic, self-renewing, and undifferentiated cells. Under the proper 
signals or stimulations, they can give rise (differentiate) into different cell types (lineages). In the 
body, tissue stem cell lineage is determined by a stem cell microenvironment or niche.  A niche 
provides proper signals which determine the differentiation of local stem cells toward a specific 
lineage. However, stem cells have plasticity; by implanting them into a totally different niche, 
they may differentiate into cell types resembling those of their new environment [11]. This 
differentiation capability makes them very useful for regenerative medicine.  Based on their 
origin, there are two main types of stem cells: Embryonic stem cells (ESCs) derived from the 
inner cell mass (ICM) of a blastocyst [12]; and adult stem cells (AdSCs), found within most, if 
not all, adult tissues. Stem cells can also be classified based on their differentiation potential: 
Totipotent stem cells can give rise to an entire organism, including all three embryonic germ 
layers (e.g. ectoderm, endoderm and mesoderm) plus placenta; pluripotent stem cells can give 
rise to every type of cell from all three germ layers but not to the extra-embryonic structures; and 
multipotent stem cells can only give rise to limited cell types, usually within the same germ layer 
of tissues in which they reside [13].  
1.2.1 Embryonic stem cells (ESCs) 
ESCs are derived from the inner cell mass (ICM) from an early developmental stage of 
the embryo [14].  ESCs are pluripotent, and can maintain an undifferentiated state and normal 
karyotype for at least 80 passages [15, 16].  However, isolation of ESCs requires the destruction 
of embryos which raises legal and moral controversies [1].  Another drawback to the use of 
ESCs is immune rejection.  Because autogenous transplantation of ESCs is not feasible, 
transplantation between genetically unrelated individuals may generate severe immune 
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responses. In order to avoid graft rejection, matching alloantigens, including major 
histocompatible complex (MHC) antigens, is important. In addition, transplantation of ESCs has 
been shown to form tumors (teratomas) in vivo [2, 3]. Therefore, tumorigenicity of ESCs has 
become a major concern in the application of these cells.   
1.2.2 Adult stem cells (AdSCs) 
AdSCs exist in most, if not all, adult tissues functioning as a source of cells for normal 
tissue turnover and regeneration/repair of damaged tissues. AdSCs have multipotent 
differentiation capability; i.e., they can differentiate into limited types of cells [17].  AdSCs 
generally generate those cell types found in the tissue in which they reside.  However, given 
proper stimulation, AdSCs can differentiate into cell types from other tissues [18-21]. AdSCs can 
be isolated and used in the same patient as an autograft, which eliminates the risk of graft 
rejection. Another advantage of AdSCs is that, in contrast to ESCs, they are generally not 
tumorigenic.  
However, due to the limited quantity of AdSCs in given tissues, in order to have a 
sufficient number of cells for the clinical applications, the primary isolated AdSCs usually need 
to be expanded via in vitro culture. Studies demonstrated that in vitro expansion of AdSCs may 
influence both the proliferation and differentiation potentials of the cells [22, 23].  Study of 
human bone marrow stem cells (BMSCs) demonstrated decreased differentiation capability after 
multiple population doublings [24].  Different AdSCs lose their differentiation capability at 
different passage numbers. BMSCs, for instance, lose their differentiation capability around 
passage 6 [25, 26], while adipose-derived stem cells maintain their ability to differentiate into 
adipocytes until passage 10 [27]. In contrast, stem cells derived from human umbilical cord 
maintain their differentiation capability for a longer period of time until passage 18 [28].  Loss of 
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differentiation capability during in vitro expansion dramatically impacts the utilization of the 
AdSCs for regenerative medicine. As in many cases, it is impossible to continuously obtain 
tissues from a given patient for stem cell isolation. Efforts have been attempted to maintain 
AdSCs differentiation capability when cultured in vitro, but with limited success.  
1.2.3 Induced pluripotent stem cells (iPSCs)  
Another type of stem cell is iPSCs, which are produced by converting differentiated cells 
into pluripotent stem cells.  The technique was first demonstrated in murine fibroblasts [4] and 
later in human [5] by reprogramming somatic cells with epigenetic expression of transcription 
factors, such as OCT3/4, SOX2, KLF4, and C-MYC [4].  iPSCs resemble ESCs, in that they can 
differentiate into all three germ layers and have a similar proliferation pattern [29].  Although use 
of these cells raises no ethical concerns, there is a risk of tumorigenicity, either by gene 
disruption due to DNA insertion or by activation of oncogenes [30].  Generation of iPSCs 
without introducing viral vectors has been reported [31].  It has been shown that repeated 
transfection with expression plasmids containing reprogramming genes results in generation of 
iPSCs without DNA integration [31].  A recent study showed that in vivo directed differentiation 
of iPSCs toward the specific lineage may minimize teratomas formation [32]. 
1.3 DENTAL STEM CELLS    
AdSCs have been also isolated from dental tissues. Since the discovery of the AdSCs in 
dental pulp [33], several other types of dental stem cells (DSCs) were successfully isolated from 
various dental tissues including periodontal ligament (PDL) [34], exfoliated deciduous teeth 
[35], root apical papilla [36], and the dental follicle (DF) [8-10]. DSCs can be classified in two 
categories based on their differentiation potentials toward the dentin or periodontium tissues (i.e., 
tooth supporting tissues including PDL, alveolar bone, and cementum). Dental pulp stem cells 
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(DPSCs), stem cells from apical papilla (SCAPs) and stem cells from exfoliated deciduous teeth 
(SHEDs) are classified in the first group and associated with the dental pulp complex formation. 
The second group includes stem cells from dental follicle (DFSCs) and stem cells isolated from 
PDL (PDLSCs) and related to the formation of periodontium. Table 1.1 summarizes some of the 
differentiation properties as well as some of the surface markers that have been reported to be 
associated with different types of DSCs [37-41].  
DSCs share some similarities with BMSCs, which are the most studied AdSCs. They 
possess multilineage differentiation properties, self-renewal capability, as well as colony-
forming efficiency [8-10].  Obtaining BMSCs requires bone marrow aspiration, which is a 
painful and invasive procedure. Furthermore, the frequency and differentiation potentials of 
these cells are significantly age-related [42]. Therefore, considerable attention has been paid to 
stem cells from dental tissues that can be obtained from discarded medical wastes during dental 
procedures. For example, DF can be obtained from extracted impacted teeth.  Moreover, DSCs 
are derived from the neural crest, a different origin from mesoderm-derived BMSCs [43]. This 
may make DSCs a better choice for repair of damages in neural crest-derived tissues, including 
periodontium and craniofacial defects. Several studies have also investigated the differentiation 
capability of DSCs toward the neuronal direction to explore their potential applications for 
treatment of neural diseases [44-46].   
1.4 DENTAL FOLLICLE AND DENTAL FOLLICLE STEM CELLS  
The dental follicle (DF) is a loose connective tissue surrounding an unerupted tooth. It 
plays an important role in the coordination of tooth eruption [47].  DF produces growth factors 




Table 1.1 Differentiation capabilities and marker genes reported to be associated with different 




Cell types  
In vitro 
multipotency 
Ectopic tissue formation in vivo  Major marker genes  









Dentin-like formation  
Bone-like formation 
STRO-1, CD13, 
CD29, CD44, CD59, 
CD73, CD90, D105, 
CD146, NESTIN 










Dentin-like formation  
Bone-like formation 
STRO-1,  CD13, 
CD29, CD44, CD73, 
CD90, CD105, 
CD146, CD166 










CD24, CD29, CD44, 
CD73, CD90, D105, 
CD106, CD146, 
NESTIN 













CD29, CD44, CD59, 
CD73, CD90, CD105 







PDL-like formation   
Bone-like formation  
Cementum-like formation 
STRO-1, CD13, 
CD29, CD44, CD59, 





During tooth development, the DF is separated from dentin by an epithelial layer, which 
is called Hertwing´s sheet. This sheet disintegration during tooth root development enables a 
contact between ectomesenchymal cells of the DF and the dentin surface [49, 50].  Such contact 
subsequently causes DF cells to differentiate into periodontium including the alveolar bone, 
cementum, and periodontal ligament (PDL) [51-53].  This biological function suggests the 
presence of stem cells in the DF.  Several studies have reported the isolation of progenitor/stem 
cells from DF in different species, using an enzymatic digestion of the DF to release cells, 
followed by a culture of the cells in a stem cell growth medium [8-10].  The resultant cell 
population was identified as DFSCs as the cells possess multipotent differentiation capability [8].   
Similar to other mesenchymal stem cells, DFSCs adhere to plastic and can form colonies [9].  In 
addition, they are characterized by a high proliferation rate, as well as expression of 
mesenchymal and neural stem cell markers listed in Table 1.2 [37-40].  
  Multilineage differentiation capability of DFSCs has been shown in vitro in various 
studies. DFSCs have been shown to have a greater differentiation capability toward the 
osteogenic lineage in comparison to DPSCs which tend to differentiate toward the odontoblasts 
[54].  Previous studies in our laboratory revealed that rat DFSCs have the capability to 
differentiate into adipocytes, neuroblasts, neurosphere and osteoblasts [8, 55].  Others reported 
that mouse DFSCs can differentiate toward the adipocytes, chondrocytes and osteoblasts [56].  
Studies on human DFSCs showed a discrepancy in the multiple differentiation potential [57-59]. 
Human DFSCs isolated during early root development showed differentiation toward the 
adipocytes, chondrocytes and osteoblasts [58]. However, DFSCs isolated from the apex of 
human tooth root at a later stage of root development showed adipogenesis and osteogenesis, but 
no chondrogenesis capability [59]. These studies suggest that the DFSCs isolated from the DF of  
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Table 1.2 Mesenchymal and neural stem cell markers reported to be expressed in DFSCs [37-40] 
 
different developmental stages may affect differentiation potential. Despite these discrepancies 
within different laboratories, they all confirmed the strong differentiation capability of DFSCs 
toward the osteoblast lineage.  Moreover, other studies revealed that the DF contains 
heterogeneous stem cells consisting of different subpopulations of stem cells varying in cell 
morphology, gene expression pattern, as well as differentiation capability.  However, 
heterogeneity in a DFSC population does not affect their bone formation capability [60] 
Due to the small size of the DF tissue, primary isolated DFSCs need to be expanded in 
vitro until sufficient numbers of cells are obtained.  Optimization of the culture conditions to 
Gene Abbreviation Description 
Aminopeptidase-N CD13 Mesenchymal stem cell marker 
Integrin beta-1 CD29 
Mesenchymal  and neural stem cell 
marker 
Transmembrane receptor to 
hyaluronan 
CD44 
Mesenchymal  and cancer stem-like cell 
marker 
Protectin CD59 Mesenchymal stem cell marker 
Ecto-5-prime-nucleotidase 
(NT5E)  
CD73 Mesenchymal stem cell marker 
Thy-1 membrane glycoprotein CD90 Mesenchymal stem cell marker 
Endoglin CD105 Mesenchymal stem cell marker 
Melanoma cell adhesion 
molecule (MCAM) 
CD146 Mesenchymal stem cell marker 
Trypsin-resistant cell surface 
antigen 
STRO-1 Mesenchymal stem cell marker 
Notch homolog 1 NOTCH1 Neural stem cell marker 
Nestin NESTIN Neural stem cell marker 
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grow and maintain DFSC properties is under investigation.  The role of various factors in DFSCs 
proliferation and differentiation has been evaluated [61].  Studies suggest that Collagen type I is 
effective for both growth and osteogenic differentiation of the DFSCs.  Also, fibronectin has 
been shown to enhance cell proliferation, and therefore it can be useful for rapid proliferation of 
DFSCs. Elucidation of the roles of different growth factors for maintaining DFSC properties 
would facilitate the establishment of the optimal culture conditions for proliferation of DFSCs. 
1.5 IN VIVO HARD TISSUE-FORMING POTENTIAL OF DFSCS 
Differentiation capability of DFSCs along osteogenic pathways in vitro suggests that they 
can be used for in vivo bone reconstruction/regeneration.  However, limited studies have been 
conducted to evaluate in vivo bone formation of DFSCs.  Subcutaneous transplantation of bovine 
and human DFSCs mixed with hydroxyapatite/tricalcium phosphate (HA/TCP) ceramics showed 
formation of mineralized structure on the border of the ceramics [62, 63]. Two other studies 
investigated DFSCs for bone regeneration in critical-size defects created in the calvarium of 
immuno-deficient rats. The first study compared the osteogenic lineage differentiation potential 
of porcine DFSCs, PDLSCs and alveolar BMSCs [61].  Bone formation was observed after 
transplantation of these stem cells showed no statistical difference. The second study evaluated 
the bone formation potential of the different subpopulations of human DFSCs and found that 
transplantation of different cell populations promoted bone formation at the same extent [60].  In 
both studies, the new bone formation was similar to that seen in intramembranous ossification 
because there was no intermediate cartilage formation, indicating no endochondral ossification.  
However, no scaffolds were used for those experiments, and only DFSC pellets were 
transplanted.  Scaffolds are important components in stem cell-based tissue engineering.  
Particularly, they are required for regeneration of larger defects. 
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1.6 USE OF SCAFFOLDS IN TISSUE ENGINEERING  
Scaffolds mimic extracellular matrix and provide a physical three-dimensional structure 
to support cell attachment, migration, and differentiation [64].  In addition, they provide an 
environment for vascularization. Thus, scaffolds are an important element in tissue engineering. 
Scaffolds suitable for stem cell-based therapies should display the following properties [65]: 
1) Provide a porous structure for vascularization, while the porosity should be 
sufficient for nutrient transfer and cell attachment without compromising 
mechanical strength. 
2) Be biodegradable at the same rate as the regeneration of the new tissue. 
3) Be biocompatible to support cell attachment, growth and differentiation. 
4) Be mechanically stable during the tissue regeneration period.  
There are three major types of scaffolds for tissue engineering: (a) calcium phosphate 
ceramics including β-tricalcium phosphate (β-TCP) and hydroxyapatite (HA), which resemble 
the inorganic component of bone; (b) naturally derived scaffolds including collagen, silk, 
derivatives of hyaluronic acid, gelatin, chitosan and fibrin, which mimic bone organic 
components; and (c) synthetic polymers which can be customized to be biocompatible with 
different tissues.  Table 1.3 summarizes the advantages and disadvantages of these scaffolds. 
1.7 SPECIFIC AIMS AND SIGNIFICANCE OF THIS RESEARCH  
We hypothesize that DFSCs are a valuable type of AdSCs for bone regeneration for the 
treatment of craniofacial defects.  The overall goal of this dissertation is to further characterize 
DFSCs and to evaluate the DFSCs for the treatment of rat calvarial critical-size defects.  The 





Table 1.3 Comparison of major types of scaffolds used for tissue engineering   
 
Aim 1: Characterization of osteogenic differentiation and identification of genes highly 
expressed in DFSCs (Chapter 2). First, the osteogenic capabilities of different passages of 
DFSCs were studied, and the DFSC passages that possess strong osteogenesis were identified. 
Next, we compared the expression of stem cell-related genes in the DFSCs and in non-stem cell 
dental follicle cells (DFCs). We found that several stem cell-related genes were expressed 
substantially higher in the DFSCs than in non-stem cell DFCs, and maximal differential 
expression was seen in dentin matrix protein 1 (DMP1). The results would provide fundamental 
information for utilization of DFSCs in tissue engineering, particularly in bone regeneration.  
Aim 2: Improvement of osteogenesis of DFSCs in vitro (Chapters 3, 4).  In Chapter 3, the 
role of DMP1 in promoting osteogenic differentiation of DFSCs was evaluated.  We explored 
whether DMP1 could be added into the induction medium to promote osteogenesis of DFSCs.  
Scaffolds  Advantages Disadvantages 
1.Calcium phosphate ceramics:   
β-tricalcium phosphate (β-TCP), 
hydroxyapatite (HA) 
Osteoinductive                 
Osteoconductive                            
Support the attachment, 
growth and 
differentiation of cells  
Low mechanical 
strength 
2.Naturally derived scaffolds:   
Collagen, silk, derivatives of hyaluronic 
acid, gelatin, chitosan and fibrin 
Biocompatibility             
Biodegradability              
Osteoconductive                             
Support cell infiltration 
and vascularization 
Low biomechanical 
properties             
Relatively high 
degradation rate 
3. Synthetic Polymers:   
Poly-l-lactide acid ( PLLA), 
poly- glycolic acid (PGA), 
poly-lactic-co-glycolic acid (PLGA), 
poly-ethylene glycol (PEG), 
poly-ethylene glycol diacrylate ( PEDGA), 
poly-ethylene terephthalate ( PET), 
poly-caprolactone ( PCL) 







Moreover, it is known that AdSCs exist in a quiescent state under normal physiological 
conditions, and certain factors such as tissue injury signals can activate stem cells from 
quiescence. Hence, we hypothesized that some stressors can activate stem cells.  In Chapter 4, 
we showed that DFSCs increased self-renewal (proliferation) and differentiation by heat-stress 
treatment, suggesting that heat-stress may activate quiescent stem cells.  Further study is 
recommended to investigate whether heat-stress treatments of DFSCs would be beneficial for 
bone regeneration prior to or after in vivo transplantation.  
 Aim 3: Evaluation of DFSCs for the treatment of craniofacial defects (Chapter 5).  The 
ultimate goal of studying DFSCs is to use them for tissue repair/regeneration. Current literature 
only reports successful bone regeneration by transplanting DFSC pellets in immune-deficient 
rats [62, 60], and the results have limited value in determining the possibility of using DFSCs for 
clinical treatment of bone defects. In Chapter 5, two types of scaffolds were tested for seeding 
DFSCs, and in vivo studies were performed to test whether DFSCs could effectively repair the 
craniofacial defects. The results obtained from this aim would be significant toward the 
utilization of DFSCs in regenerative medicine. 
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CHAPTER 2: CHARACTERIZATION AND OSTEOGENIC 





Experimental evidence supports the existence of progenitor/stem cells in various dental 
tissues, including the dental follicle (DF) [1-3]. Dental follicle stem cells (DFSCs) have been 
isolated from different species and have been demonstrated to possess strong osteogenic 
capability in vitro [1-3]. Thus, they can be used for bone regeneration to treat bone defects, such 
as craniofacial defects. For isolation of human DFSCs, DFs can be obtained from extracted 
impacted teeth that are discarded as medical wastes.  However, due to the small size of the DF, 
limited quantities of primary DFSCs can be isolated. Therefore, in vitro expansion is necessary 
to obtain a sufficient number of cells for therapeutic use. Previous studies revealed that adult 
stem cells (AdSCs) lose their differentiation capabilities during in vitro culture [4, 5].  There is a 
lack of data within the literature regarding loss of differentiation capability in DFSCs during in 
vitro culture. It was our hypothesis that similar to other AdSCs, DFSCs also gradually lose their 
osteogenic differentiation potential during in vitro proliferation. It is important to determine the 
passages at which DFSCs reduce/lose their osteogenic capability, so that the proper passage cells 
can be used for therapeutic applications.  
Various studies reported an osteogenic differentiation capability of DFSCs, based on 
assessment of calcium deposition after osteogenic induction.  It is not clear whether DFSCs 
specifically differentiate toward the osteoblast lineage, because cementoblasts, odontoblasts and 
osteoblasts are all calcium-depositing cells involved in tooth development. It is reasonable to 
speculate that DFSCs, as stem cells derived from dental tissue, are likely capable of 
                                                          

 Some of the data are reprinted with permission of S. Karger AG.  Authors: Shaomian Yao, 
Hongzhi He, Dina L. Gutierrez, Maryam Rezai Rad, Dawen Liu, Chunhong Li, Michael B. 
Flanagan, Gary E. Wise. 
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differentiation toward the cell lineages related to tooth development. Thus, another objective of 
this chapter was to assess whether DFSCs can differentiate into different types of calcium-
depositing cells under the osteogenic induction condition by evaluating the expression of the 
marker genes specific in different types of calcium-depositing cells. Accomplishing of this 
objective would provide fundamental information for future applications of DFSCs for bone 
regeneration. 
Genes highly expressed in stem cells are likely to have certain functions for stem cell 
properties or can serve as biomarkers for identification and isolation of stem cells. CD73 
(membrane-bound ecto-5'-nucleotidase), CD90 (Thy1) and CD105 (endoglin) have been used as 
identification markers for mesenchymal stem cells (MSCs) [6]. STRO-1, trypsin-resistance cell 
surface antigen, was also reported to express in MSCs playing a role in controlling stem cell 
migration [7], and it also has been widely used as a marker for identification and isolation of 
different types of MSCs, such as bone marrow stem cells and stem cells from dental tissues using 
cell sorting techniques [8-12]. In addition, markers are useful for evaluation of the status of 
growth and differentiation potential of stem cells. For example, expression of vascular cell 
adhesion molecule 1(VCAM-1/CD106) and melanoma cell adhesion molecule (MCAM/CD146) 
has been used as an indication of MSCs’ multipotency [7]. Thus, the final objective of this 
chapter was to identify stem cell-related genes that are highly expressed in the DFSCs.  
2.2 MATERIALS AND METHODS 
2.2.1 Establishment of cell cultures  
Animals were handled in accordance with a protocol reviewed and approved by the 
Institutional Animal Care and Use Committee (IACUC) of Louisiana State University (LSU). 
Sprague Dawley (SD) rat pups at postnatal day 6 were used for isolation of DFs. Rat pups were 
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euthanized by isoflurane inhalation, and then the DFs were surgically collected from the first 
mandibular molars. Primary cell suspensions were obtained by digestion of the DFs with 0.05% 
Trypsin-EDTA (Invitrogen, Grand Island, NY, USA) in a 37°C incubator for 10 minutes and 
centrifuged for 5 minutes at 3000 rpm to collect cell pellets. Next, trypsin was removed and cell 
pellets were re-suspended in the appropriate medium. The procedures for establishment of the 
DF derived cell cultures are illustrated in Figure 2.1. 
The cell suspension was subjected to two culture systems to establish dental follicle stem 
cells (DFSCs) or non-stem cell dental follicle cells (DFCs).  DFSCs were established by growing 
the primary cells in  a medium containing α-MEM (Invitrogen, Grand Island, NY, USA) + 20% 
fetal bovine serum (FBS, Atlanta Biologicals, Flowery Branch, GA, USA ) + 1% Penicillin-
Streptomycin 10,000 u/ml (Invitrogen, Grand Island, NY, USA). This medium has been used 
previously to establish dental stem cell cultures [1], and therefore is referred as stem cell growth 
medium.  For DFCs, primary cells were grown in fibroblast growth medium consisting of MEM 
(Invitrogen, Grand Island, NY, USA) + 10% newborn calf serum (NCS, Invitrogen, Grand 
Island, NY, USA) + 10 mM sodium pyruvate (Invitrogen, Grand Island, NY, USA) + 1% 
Penicillin-Streptomycin 10,000 u/ml (Invitrogen, Grand Island, NY, USA), as previously 
described [13]. Cells were cultured in plastic flasks overnight at 37
o
C and 5% CO2, and non-
adherent cells were removed by medium change. The remaining cells were cultured until they 
reached 80-90% confluency.  Cells were trypsinized and passaged at a ratio of 1:3 until the 
desired passages were reached. 
Established DFSCs and DFCs at passage 3 (P3) were evaluated for colony forming as 
well as osteogenic capability. DFSCs can form cell clusters (Figure 2.1; Section E) which were 




Figure 2.1 Schematic diagram of isolation of the DFSCs and DFCs from the DFs.  Postnatal rat 
pups were used for obtaining the DFs (A). DFs were surgically removed. Note the DF shown on 
the histological slide (B)
1
.  DFs were then trypsinized, cells were collected and  incubated either 
in stem cell growth medium for DFSCs (C) or fibroblast growth medium for DFCs (D).  DFSCs 
were able to form cell clusters (E)
2
; in contrast, no cell clusters were formed in DFC cultures (F). 
DFs: dental follicle; DFCs: dental follicle cells; DFSCs: dental follicle stem cells; FBS: fetal 
bovine serum; NCS: newborn calf serum.   
                                                          
1
 Figure 2.1; Section B is reprinted from Chapter 16 of Electroporation Protocols: Preclinical and 
Clinical Gene Medicine, Methods in Molecular Biology with permission of Springer 
Science+Business Media New York.  
2
 Figure 2.1; Sections E and F are reprinted from from a published paper by Yao S, Pan F, Prpic 
V, Wise GE. Differentiation of stem cells in the dental follicle. J Dent Res. 2008; 87(8): 767-71 




 with no differentiation ability were transferred to cryopreservation tubes, in storage medium 
consisting of 50% α-MEM medium (for DFSCs) or MEM (for DFCs), 40% FBS, and 10% 
dimethyl sulfoxide (DMSO, Sigma-Aldrich, St. Louis, MO, USA). Cells were frozen at -80°C 
overnight in Mr. FROSTY 
TM
 Freezing container (Thermo Scientific, Waltham, MA, USA) 
before being transfered to liquid nitrogen for long-term storage. 
2.2.2 Evaluation of osteogenic capability of the DFSCs and DFCs 
To determine the osteogenic capability of DF derived cells, DFSCs and DFCs were 




.  DMEM-LG (Invitrogen, Grand Island, 
NY, USA) containing 10% FBS (Atlanta Biologicals, Flowery Branch, GA, USA ) and 1% 
Penicillin-Streptomycin 10,000 u/ml (Invitrogen, Grand Island, NY, USA) was used as basal 
medium, and osteogenic induction reagents consisting of 50 µg/ml ascorbate-2 phosphate, 10
-5
 
mM dexamethasone and 10 mM β-glycerophosphate (Sigma-Aldrich, St. Louis, MO, USA) were 
added to the basal medium.  This medium was designated as the osteogenic medium, as it has 
been used previously to induce osteogenesis of stem cells [1, 14-16]. DFSCs and DFCs cultured 
in α-MEM + 20% FBS (stem cell growth medium) without osteogenic induction reagents were 
included as a control. After 14 days of incubation, cells were washed with PBS and fixed with 
10% Neutral-buffered formalin (Sigma-Aldrich, St. Louis, MO, USA). Next, cells were stained 
with 1% Alizarin Red solution (GFS Chemicals, Inc., Columbus, OH, USA) for 5 minutes. In a 
separate well, osteogenic induced DFSCs were treated with 10% EDTA (AMRESCO, Solon, 
OH, USA) before being stained with Alizarin Red to ensure that the Alizarin Red staining was 





2.2.3 Evaluation of osteogenic capability of different passages of DFSCs 
Established DFSCs were sub-cultured until desired passages were obtained. Different 




. Cells were then 
incubated in osteogenic medium. After 14 days of induction, cells were fixed and stained with 
Alizarin Red as described in Section 2.2.2.   The staining was quantitated by Image-Pro Analyzer 
version 7.0 (Media Cybernetics, Rockville, MD, USA). In particular, the intensity of Alizarin 
Red staining was determined by segmentation, followed by counting the number of pixels in the 
range of bright red. 
2.2.4 Expression of marker genes in the DFSCs and DFCs 
In order to evaluate the expression of differentiation markers in DFSCs, the DFSCs at P3 
or P5 were cultured in T-25 flasks at a cell density of 2×10
5
cells/flask and induced to 
differentiate, as described in Section 2.2.2. Cells were collected with RLT buffer for RNA 
extraction at days 7 and 14. The expression of the differentiation marker genes bone sialoprotein 
(BSP), osteocalcin (OCN), dentin sialophosphoprotein (DSPP) and F-spondin were determined 
using real-time RT-PCR.  The primers used in this study are given in Table 2.1. 
To assess the differential expression of stem cell-related genes in the DF derived cells, 
we conducted two separate experiments. In the first experiment, DFSCs and DFCs were cultured 
in T-75 flasks at a cell density of 10
6
cells/flask  in their appropriate culture medium, as described 
in Section 2.2.1; i.e., DFSCs in α-MEM + 20% FBS (stem cell growth medium) and DFCs in 
MEM + 10% NCS (fibroblast growth medium), for 7 days.  In the second experiment, we 
transferred established DFCs to stem cell growth medium and incubated for 7 days, so the 
DFSCs and DFCs were grown in the same medium condition. Cells were then collected for gene 
expression analysis by real-time RT-PCR. 
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Table 2.1 Primer pairs used for real-time RT-PCR in Chapter 2 
 
ALP: alkaline phosphatase; BMP3: bone morphogenetic protein 3; BSP: bone sialoprotein; 
BCRP: breast cancer resistance protein 1; C-KIT: receptor tyrosine kinase; DMP1: dentin matrix 
protein1; DSPP: dentin sialophosphoprotein; ESRRB: estrogen-related receptor beta. 
 
 
Gene Primer sequence GeneBank reference #  
ALP F: 5´-GACAAGAAGCCCTTCACAGC-3´ 
R: 5´-ACTGGGCCTGGTAGTTGTTG-3´ 
NM_013059.1 
BMP3 F: 5´-TACTACAGTCCCTTCCGTCTCC-3´ 
R: 5´-AAACAACCTAGCCACAGACACA-3´ 
NM_017105.1 
BSP F: 5´-ACGCTGGAAAGTTGGTAGCTG-3´ 
R: 5´-TTCCTCTTCCTCGTCGCTTTCCTT-3´ 
NM_012587.2 
BCRP F: 5´-GTTTGGACTCAAGCACAGCA-3´ 
R: 5´-AATACCGAGGCTGGTGAATG-3´ 
NM_181381.2 








DSPP F: 5´-GGGAAGCTCAGTGGAAGTAAAG -3´ 
R: 5´-CTGCTGTGTCCCATGTTGTAT-3´ 
NM_012790.2 
ESRRB F: 5´-GTGCCTGAAGGGGATATCAA-3´ 
R: 5´-AGAAACCTGGGATGTGCTTG-3´ 
NM_001008516.2 





(Table 2.1 continued) 
Gene Primer sequence GeneBank reference # 
OCN F: 5´-ACTGCATTCTGCCTCTCTGACCT-3´ 
R: 5´-TATTCACCTCCTTACTGCCCTCCT-3´ 
NM_013414.1 
F-spondin F: 5´-GACCTACGAGTCACCAAACAA-3´ 
R: 5´-CACCTTCCGGGTCATAGAAAG-3´ 
M88469.1  
TERT F: 5´-ATGTTCCTTCTGGCTAATGG-3´ 
R: 5´-TGCTCCACACACTCTTACGG-3´ 
NM_053423.1  
β-actin F: 5´-CTAAGGCCAACCGTGAAAAGAT-3´ 
R: 5´-AGAGGCATACAGGGACAACACA-3´ 
NM_031144.3 
NOTCH1: neurogenic locus notch homolog protein 1; OCN: osteocalcin; TERT: telomerase 
reverse transcriptase; β-actin: beta actin. 
2.2.5 Methods for real-time RT-PCR  
To extract total RNA, cells were lysed in RLT buffer (Qiagen, Valencia, CA, USA) and 
centrifuged at 13000 rpm for 3 minutes. RNA isolation was performed from the supernatants 
with the RNeasy® Mini kit, according to the manufacturer´s description (Qiagen, Valencia, CA, 
USA). RNA Concentration was determined with a Nanodrop 8000 (Thermo Scientific, Waltham, 
MA, USA). RNA was reverse-transcribed into cDNA with M-MLV Reverse Transcriptase 
(Invitrogen, Grand Island, NY, USA). Briefly, equal amounts of RNA were mixed with 250 ng 
random primer (Invitrogen, Grand Island, NY, USA) and reverse-transcription buffer. Reverse 
transcription was performed at 37°C for 50 minutes followed by heating at 70°C for 15 minutes 
to inactivate the reaction. cDNA templates were used for SYBR Green real-time PCR to detect 
cycle threshold (CT) values with Applied Biosystems’ 7300  Real-Time PCR System. The CT 
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values were normalized to β-actin to calculate ΔCT. Relative gene expression (RGE) was 
calculated with the formula 2
-ΔΔCT 
using the control as the reference (RGE=1) [17]. 
2.2.6 Expression of DMP1 protein in the DFSCs and DFCs  
For assessment of DMP1 expression at protein level in the DF derived cells, DFSCs and 
DFCs were harvested after 7 days culture in their original culture medium using CytoBuster
TM
 
protein extraction buffer (EMD Millipore, Billerica, MA, USA) supplemented with 1/50 Protease 
Inhibitor cocktail (Santa Cruz Biotechnology, Inc. Dallas, TX, USA).  After centrifugation of the 
cell lysate, supernatants containing total protein were transferred to new tubes, and protein 
concentration was determined with the BCA protein assay (Thermo Fisher Scientific, Waltham, 
MA, USA). Total protein (15 µg) of each sample was subjected to electrophoresis on 10% SDS-
PAGE and transferred onto a PVDF membrane (Bio-Rad, Hercules, CA, USA). Membranes 
were incubated with a polyclonal rabbit anti-DMP1 antibody (Abnova Corporation, Walnut, CA, 
USA) or rabbit anti-actin polyclonal antibody (Abcam, Cambridge, MA, USA). The membrane 
was subsequently incubated with goat anti-rabbit IgG and then washed with PBST buffer to 
remove unbound antibody.  The membrane was developed with enhanced chemiluminescence 
detection reagents (Santa Cruz Biotechnology, INC.  Dallas, TX, USA). 
2.2.7 Statistical analysis 
All experiments were repeated a minimum of N=3 times. Analysis of variance (ANOVA) 
and least significant difference (LSD) were used for multiple comparisons of more than two 
means with SAS program version 9.3 (SAS, Cary, NC, USA). A student T-test was used for 
comparison of two means to obtain the P-values for determination of statistical significance. 





2.3.1 Osteogenic differentiation of DF derived cells 
Two distinct populations of cells were established from the DFs and designated as 
DFSCs and DFCs. Both DFSCs and DFCs were subjected to osteogenic differentiation 
induction, and Alizarin Red staining was conducted to assess calcium deposition after 14 days of 
incubation (Figure 2.2). The wells containing DFSCs showed positive staining when cultured in 
osteogenic induction medium (Figure 2.2; Section A). In contrast, the wells containing DFSCs 
cultured in stem cell growth medium (α-MEM + 20% FBS) or basal medium (DMEM-LG + 
10% FBS) without the addition of osteogenic induction reagents did not show any staining 
(Figure 2.2; Sections B and C). No staining was seen in the DFCs in any of the treatment groups 
(Figure 2.2; Sections D, E and F). This differentiation assay confirmed that the DFSCs contained 
stem/progenitor cells capable of osteogenic differentiation, whereas the DFC population 
contained no stem cells/precursor cells. In addition, DFSCs did not spontaneously differentiate 
into calcium-depositing cells in stem cell growth medium.  
To ensure that the Alizarin Red staining seen was calcium deposition, some wells were 
treated with 10% EDTA prior to staining. We found that the tentative calcium deposition could 
be completely removed by EDTA, such that no Alizarin Red staining could be seen in EDTA-
treated wells (Figure 2.3; Section C), indicating that these deposits were calcium.    
2.3.2 Expression of differentiation marker genes in DFSCs in response to osteogenic 
induction  
 
Calcium can be deposited by a variety of cells, including cementoblast, odontoblasts and 
osteoblasts. Alizarin Red staining detects only overall calcium deposition.  To determine whether 
DFSCs can differentiate into different calcium-depositing cells, we further evaluated the 




Figure 2.2 Evaluation of calcium deposition in the DFSCs and DFCs cultured in different 
medium as shown by Alizarin Red staining.  Note that Alizarin Red staining was detected only in 
the DFSCs incubated in medium containing osteogenic induction reagents (A), but not in either 
basal medium (B) or stem cell growth medium (D) without the induction reagents.  In contrast, 
DFCs did not display any calcium deposition in all treatment groups (D-F). DFCs: dental follicle 
cells; DFSCs: dental follicle stem cells; FBS: fetal bovine serum.     
 
 
Figure 2.3 EDTA treatment to ensure 
calcium deposition in Alizarin Red 
staining. Alizarin Red positive staining 
was seen only when cells were cultured 
in the differentiation medium (A); no 
Alizarin Red staining was seen in the 
DFSCs cultured in basal medium without 
induction reagents (B); and 10% EDTA 
treatment of the cultures prior to Alizarin 
Red staining completely removed the 
calcium depositions and resulted in no 
staining in the induced cells (C), similar 
to the non-induced cells (D). DFSCs: 
dental follicle stem cells; EDTA: 
Ethylenediaminetetraacetic acid; FBS: 
fetal bovine serum.    
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cementoblast (F-spondin) before and after induction. The results are presented in Figure 2.4. 
After 7 days of induction, the expression of BSP and OCN was significantly increased in DFSCs, 
with the RGE of 59.69 ± 6.84 for BSP and 307.12 ± 70.64 for OCN compared to undifferentiated 
control (RGE=1), indicating that the DFSCs underwent osteogenic differentiation.  Expression of 
these two markers continued to increase significantly until day 14 (Figure 2.4; Sections A and 
B).  In contrast to BSP and OCN, we observed minimal changes in expression of the odontoblast 
(DSPP) and cementoblast markers (F-spondin). DSPP expression was decreased after 7 days of 
induction when compared to controls.  Although the average RGE of 5.48 ± 2.61 was seen after 
14 days of induction, the increase was not statistically significant compared to undifferentiated 
controls (Figure 2.4; Section C). The increase in expression of F-spondin was not statistically 
significant after 7 days of induction, and expression was decreased about 90% (i.e., RGE of 0.1) 
after 14 days of induction (Figure 2.4; Section D). The increased expression of the osteoblast 
markers and decreased expression of the cementoblast and odontoblast markers suggested that 
the DFSCs differentiated toward the osteoblast lineage under the osteogenic induction 
conditions.  
2.3.3 Osteogenic capability of DFSCs during in vitro expansion 
When different passages of DFSCs were subjected to osteogenic induction for 14 days 
(Figure 2.5), the maximum osteogenesis was observed in the DFSCs at P3 and P5, as revealed by 
Alizarin Red staining. A reduction in staining was noted by P7.  The calcium deposition was 
reduced dramatically by P9.  By P11, DFSCs lost their osteogenic differentiation capability 
completely (Figure 2.5; Section A).  The staining was measured quantitatively with Image-Pro 
Analyzer, and data were analyzed statistically. Significant reduction in staining was seen in P7 and 

































































































































































































































































































































































































































































































































































































































































































































































































































osteogenic capability during in vitro culture with complete loss of the ability occurring around 
P11. 
2.3.4 Expression of stem cell-related genes in the DFSCs and DFCs 
Using real-time PCR, we evaluated the expression of 40 stem cell-related genes in 
DFSCs vs. DFCs. The result revealed that 14 genes were expressed higher in the DFSCs than in 
DFCs, when the cells were grown in the original medium for establishing the cultures described 
in Section 2.2.1. Of the 14 genes, 8 genes showed statistically higher in the DFSCs than in the 
DFCs (Figure 2.6), and no statistical significance was determined in other 6 genes (data not 
shown).   The maximum difference was seen in dentin matrix protein 1 (DMP1), with RGE of 
856 ± 152.94, indicating an average of more than 850-fold higher in DFSCs compared to DFCs 
(RGE=1).  In addition to DMP1, the genes that expressed over 10-fold higher in DFSCs were 
telomerase reverse transcriptase (TERT), estrogen-related receptor beta (ESRRB), bone 
morphogenetic protein 3 (BMP3), receptor tyrosine kinase (C-KIT) and neurogenic locus notch 
homolog protein 1 (NOTCH1). The differences were statistically different in these genes. To 
determine the possible medium effect, both DFSCs and DFCs were incubated in α-MEM + 20% 
FBS (used for growth of stem cells) for 7 days before collecting the cells for real-time RT-PCR 
analysis. A similar trend of RGE was observed for these genes; however, a huge increase of the 
average RGE for DMP1 was observed (Figure 2.7). To confirm the DMP1 expression at the 
protein level, western blotting was conducted. The result of western blotting was generally 
consistent with RT-PCR result.   A clear DMP1 protein band was seen for the DFSCs, whereas 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































Stem cells have been demonstrated to exist in the DFs of different species [1-3]. This 
study demonstrated that the DFSCs isolated from rats can be induced to differentiate into 
calcium-depositing cells.  Because cementoblasts, odontoblasts and osteoblasts are capable of 
depositing calcium and are involved in tooth development, it is interesting to determine whether 
the DFSCs can differentiate into these cells under the induction condition used in this study. We 
examined the expression of marker genes specific for these calcium-depositing cells in DFSCs 
before and after induction. Based on the differentiation marker expression results, we conclude 
that DFSCs can be induced into calcium-depositing cells primarily toward the osteoblast lineage. 
The marker genes used for this assessment are specific for given lineages of differentiation as 
discussed below.     
BSP has been suggested as a marker of osteoblast differentiation [18]. Studies suggested 
that a decrease in the level of BSP expression has a negative effect on osteoblast differentiation 
[19, 20]. OCN is secreted by the osteoblasts [21] and has been used as a marker for bone 
formation in various studies [22, 23]. DSPP is a specific marker for odontoblast differentiation 
[24, 25], and mutations in this gene have been associated with impaired dentinogenesis [26]. F-
spondin expression was observed in cementoblasts derived from the periodontal ligament [27]. It 
has been identified as a promoting factor for cementoblast differentiation [28]. Evaluating the 
expression of these differentiation markers, we found that when subjecting DFSCs to induction 
Figure 2.8 Comparison of DMP1 expression 
in the DFSCs and DFCs at protein level. 
Western blotting analysis indicated that the 
DMP1 protein band was seen in the DFSCs, 
but not clearly seen in the DFCs. DFCs: 
dental follicle cells; DFSCs: dental follicle 





medium, more than 100-fold increased expression of the BSP and OCN (osteogenic markers) 
was observed.  In contrast, the expression of an odontoblast marker, DSPP, did not change 
significantly after osteogenic induction.   No significant increased expression of F-spondin 
(cementoblast marker) was observed. In fact, decreased expression of F-spondin was seen after 
induction. These results suggested that DFSCs were induced mainly to differentiate into the 
osteoblast lineage, but not cementoblast or odontoblast lineage. Differentiation into odontoblasts 
and cementoblasts, if any, would be very minimal under the induction conditions used in this 
study.  A similar study on mouse immortalized DFSCs demonstrated the absence of amelogenin 
(ameloblast marker) and DSPP after 21 days of induction [29].  
AdSCs lose their differentiation capabilities over time during in vitro culture [4, 5]. 
Different types of AdSCs lose their differentiation capability at different passages. Study of bone 
marrow stem cells (BMSCs) has demonstrated decreased differentiation capability along with 
morphological changes after multiple population doublings [30]. It has been reported that 
BMSCs lose their differentiation capability around P6 [31, 32], and adipose-derived stem cells 
maintain their ability to differentiate into adipocytes until P10 [33]. In contrast, stem cells 
derived from human umbilical cord maintain their differentiation capability for longer periods of 
time (P18) [34]. Since transplantation of high-differentiation potential stem cells is desired for 
maximal tissue regeneration, knowing the differentiation capability of in vitro cultured stem cells 
is essential before their transplantation. In this regard, we evaluated the osteogenic capability of 
DFSCs from early to late passages. We found that DFSCs at P3 or P5 have maximal osteogenic 
differentiation potential, thus they are suitable for in vivo transplantation for bone regeneration.  
However, limitation may exist regarding comparing cell passages due to variation in handling 
cell sub-cultures in different laboratories. We passage the cells at a ratio of 1 to 3 (i.e., 1 flask to 
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3 flasks) when the cultures reach 90% confluency, this protocol is commonly practiced for 
mammalian cell cultures [35].       
Extensive studies have been carried out to identify specific marker genes for stem cells. 
However, no single definitive marker has been discovered specific for MSCs. The International 
Society for Cellular Therapy (ISCT) has proposed several markers as minimal criteria for 
identification of MSCs: MSCs must express CD73 (membrane-bound ecto-5'-nucleotidase), 
CD90 (Thy1) and CD105 (endoglin), and they must be negative for haematopoietic markers 
including CD34 and CD45 [6]. Other studies have reported the expression of mesenchymal and 
neural stem cell markers in DFSCs, including STRO-1 (trypsin-resistant cell surface antigen), 
CD13 (aminopeptidase-N), CD29 (Integrin beta-1), CD44 (Transmembrane receptor to 
hyaluronan), CD59 (protectin), CD146 (Melanoma cell adhesion molecule), NOTCH1 and 
NESTIN [36-38]. Markers are also useful for evaluation of the status of growth and 
differentiation potential of stem cells. For example, expression of vascular cell adhesion 
molecule 1(VCAM-1/CD106) and melanoma cell adhesion molecule (MCAM/CD146) has been 
used as an indication of MSCs’ multipotency [7]. This study compared expression of 40 stem 
cell-related genes in DFSCs vs. non-stem cell DFCs, both of which were established from the 
DF. We found that DFSCs express more than 10-fold of TERT, ESRRB, BMP3, C-KIT, 
NOTCH1 and DMP1 than do DFCs in the same or different culture medium. These genes may 
be considered to serve as potential makers for identification and assessment of DFSCs.  It would 
be interesting to determine whether these genes play any regulatory roles in proliferation and 
differentiation of DFSCs.  
In conclusion, we demonstrated the differentiation of DFSCs toward the osteoblast 
lineage, which makes them suitable for repair of skeletal defects. We also showed that DFSCs 
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reduced their osteogenic capability during in vitro expansion, and DFSCs at P3-P5 should be 
used for in vivo transplantation studies.  Furthermore, we determined that DFSCs appear to 
express a high level of DMP1.   
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CHAPTER 3: THE ROLE OF DENTIN MATRIX PROTEIN 1 (DMP1) IN 
REGULATION OF OSTEOGENIC DIFFERENTIATION OF DENTAL FOLLICLE 
STEM CELLS (DFSCS)  
 
3.1 INTRODUCTION 
In Chapter 2, we reported obtaining two distinct cell populations from the dental follicle 
(DF), a loose connective tissue sac surrounding the unerupted tooth, using different cell culture 
systems.  The cells derived from α-MEM + 20% Fetal Bovine Serum (FBS) were capable of 
multipotent differentiation and were designated as dental follicle stem cells (DFSCs).  In 
contrast, cells grown in MEM + 10% Newborn Calf Serum (NCS) had no differentiation 
capability [1], but possessed the characteristics of fibroblasts.  These latter cells were designated 
as dental follicle cells (DFCs) [2].  Others have reported the isolation of progenitor or precursor 
cells from the DF that could be induced to differentiate into calcium-depositing cells [3, 4].  
Thus, like other adult tissues, the DF contains adult stem cells (AdSCs) that would be valuable 
for tissue regeneration, such as for bone and craniofacial tissue reconstruction/regeneration [5].  
Elucidation of the genes and factors involved in regulating osteogenic capability of DFSCs could 
facilitate the development of cell-based therapies using DFSCs. 
Dentin matrix protein 1 (DMP1) is present in mineralized tissues [6] and is highly 
expressed in osteoblasts [7] and odontoblasts [8].  Several studies have confirmed that DMP1 
can participate in both the intra- and extracellular biomineralization process.  The acidic domains 
of DMP1 can function as a nucleator for hydroxyapatite formation in the extracellular matrix [9].  
DMP1 protein was also found in the nucleus during early differentiation of odontoblasts and 
osteoblasts [10, 11].  In addition, it is believed that in undifferentiated preosteoblasts, DMP1 
                                                          

 A manuscript developed from this chapter has been submitted to the Archive of Oral Biology. 
The manuscript is currently under revision. Authors: Maryam Rezai Rad, Dawen Liu, Hongzhi 
He, Hunter Brooks, Gary E. Wise, Shaomian Yao. 
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functions as a transcriptional factor to activate osteoblast-specific genes for osteoblast 
differentiation [10]. 
The expression of DMP1 in all non-mineralized structures surrounding developing teeth 
has been documented [12].  One such tissue is the DF. Because the DF appears to regulate the 
osteogenesis required for tooth eruption [13], and in Chapter 2, we found that DMP1 is highly 
expressed in the DFSCs, but not expressed in the non-stem cell DFCs, we hypothesized that 
DMP1 plays an important role in regulating the osteogenic differentiation of DFSCs.  The 
objectives of this chapter were to determine (a) the correlation between DMP1 expression and 
the osteogenic capability of different passages of DFSCs; and (b) if DMP1 can function to 
promote osteogenic differentiation of DFSCs.  
3.2 MATERIALS AND METHODS 
3.2.1 Cell cultures 
 Animals were handled in accordance with a protocol reviewed and approved by the 
Institutional Animal Care and Use Committee (IACUC) of Louisiana State University (LSU).  
Rat pups at day 6 were euthanized by isoflurane inhalation, and DFs were surgically isolated 
from the first mandibular molars.  Primary cells were obtained by trypsinization of the DFs. 
DFSCs and homogeneous non-stem cell DFCs were established by growing the primary cells in 
either a stem cell growth medium or a fibroblast growth medium as described in Chapter 2 
(Section 2.2.1).  After establishment of the primary cultures of DFCs and DFSCs, the cultures 
were trypsinized at 80-90% confluency and passaged until the desired passages were reached.  
Cells used for all experiments were cultured at 37
o






3.2.2 Correlation of DMP1 expression and osteogenic differentiation in different passages 
of DFSCs 
 
  DFSCs of passages 3, 5, 7 and 9 were collected with RLT buffer (Qiagen, Valencia, CA, 
USA) for total RNA extraction, and real-time RT-PCR was conducted to determine the relative 
gene expression (RGE).  The CT values were normalized using β-actin as the internal control to 
calculate ΔCT.  RGE was calculated via the formula 2
-ΔΔCT
 using the passage 3 as the reference 





.  Cells were then incubated in osteogenic medium. After 14 days of induction, 
the cells were fixed and stained with Alizarin Red using the method stated in Chapter 2 (Section 
2.2.2) and  the staining was quantitated by Image-Pro Analyzer version 7.0 (Media Cybernetics, 
Rockville, MD, USA) as described in Chapter 2 (Section 2.2.3).  Next, the correlation between 
DMP1 expression and osteogenesis in different passages of DFSCs was analyzed using SAS 
program version 9.3 (SAS, Cary, NC, USA).  
3.2.3 Transfection of DFSCs with DMP1-siRNA 
A Dicer substrate siRNA was obtained from Integrated DNA Technologies (IDT, 
Coralville, IA, USA) by annealing two single stranded RNA: sense strand 5’-
rCrGrArCrCrArCrArGrUrGrArUrGrArGrGrCrArGrArCrAGC-3’ and anti-sense strand 5’-
rGrCrUrGrUrCrUrGrCrCrUrCrArUrCrArCrUrGrUrGrGrUrGrGrUrC-3’.  The siRNA was 
designed to target the rat DMP1 mRNA.  To knock down gene expression, the DFSCs at 




and cultured until 
70% confluency at the time of transfection.  Transfection was carried out using Lipofectamine
TM
 
RNAiMAX per manufacturer’s instructions (Invitrogen, Grand Island, NY, USA).  Briefly, the 
siRNA and transfection reagent were diluted to 100 nM with Opti MEM I reduced serum 
medium (Invitrogen, Grand Island, NY, USA).  After 5 minutes of incubation at room 
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temperature, the siRNA and transfection reagent were mixed and incubated at room temperature 
for another 25 minutes to allow the formation of a siRNA- RNAiMAX complex.  The resultant 
complex was added to the DFSC culture to bring the final siRNA concentration to 10 nM.  A 
scrambled siRNA was transfected into the cells as the control.  Knockdown of DMP1 expression 
was confirmed by real-time RT-PCR.  Transfected DFSCs were cultured in the osteogenic 
differentiation medium for 14 days.  The siRNA transfection was repeated at day 7 during the 14 
days of osteogenic induction to ensure continuous knockdown of DMP1 expression.  The cells 
were then stained with Alizarin Red to evaluate the calcium deposition.  
To assess the effect of DMP1 knockdown on expression of osteogenic-related genes, 
transfected DFSCs were collected after 7 and 14 days of induction for analysis of the expression 
of selected genes using real-time RT-PCR with the primers listed in Table 3.1.  Briefly, total 
RNA was extracted from the cells and 1 µg total RNA was reverse-transcribed into 20 µl cDNA.  
SYBR green real-time PCR was conducted with 0.5 μl cDNA from each sample in each PCR 
reaction to obtain the CT values.  The CT values were normalized to β-actin for calculation of 
ΔCT.  RGE was calculated using ΔΔCT method with untransfected DFSCs as the reference 
(RGE=1) [14].  
3.2.4 Effect of exogenous DMP1 on osteogenic differentiation of DFSCs 
The recombinant mouse DMP1 (rmDMP1) was purchased from R & D system 
(Minneapolis, MN, USA).  DFSCs at passage 9 that had reduced endogenous DMP1 expression 
and reduced differentiation capability were incubated with osteogenic medium plus different 
concentrations (0-250 ng/ml) of rmDMP1.  After 14 days of incubation, Alizarin Red staining 




 Table 3.1 Primer pairs used for real-time RT-PCR in Chapter 3 
BGN: biglycan; BMP2: bone morphogenetic protein 2; BMP5: bone morphogenetic protein 5; 
BMP6: bone morphogenetic protein 6; DMP1: dentin matrix protein1; FLT1: fms-related 
tyrosine kinase 1; MMP13: matrix metallopeptidase 13 (collagenase 3); RUNX2: runt-related 
transcription factor 2; β-actin: beta actin. 
 
Gene Primer sequence GeneBank reference# 
BGN F: 5´-AGAATGGGAGCCTGAGTTTTCT-3´ 
R: 5´-ACCTTGGTGATGTTGTTGGAGT-3´ 
NM_017087.1 
BMP2 F: 5´-CTCAGCGAGTTTGAGTTGAGG-3´ 
R: 5´-GGTACAGGTCGAGCATATAGGG-3´ 
NM_017178.1 
BMP5 F: 5´-AATTTGGGCTTACAGCTCTGC-3´ 
R: 5´-AGAAGAACCTCACTTGCCTTGA-3´ 
NM_001108168.1 
BMP6 F: 5´-CTTACAGGAGCATCAGCACAGA-3´ 
R: 5´-GTCACCACCCACAGATTGCTA-3´ 
NM_013107.1 




FLT1 F: 5´-ACAGAAGAGGATGAGGGTGTCT-3´ 
R: 5´-ATCAGCTCCAGGTTTGACTTGT-3´ 
NM_019306.1 
MMP13 F: 5´-TTTATTGTTGCTGCCCATGA-3´ 
R: 5´-GAGAGACTGGATTCCTTGAACG-3´ 
NM_133530.1  
RUNX2 F: 5´-TACTTCGTCAGCGTCCTATCAG-3´ 
R: 5´-ATCAGCGTCAACACCATCATT-3´ 
NM_053470.2 





3.2.5 Statistical analysis 
All experiments were repeated a minimum of N=3 times. Analysis of variance and least 
significant difference (LSD) were used for multiple comparisons of more than two means.  A 
student T-test was used to compare the expression of osteogenic marker genes in DMP1-siRNA 
transfected DFSCs versus the control transfection.  Pearson correlation analysis was performed 
to determine the correlation between DMP1 expression and osteogenesis in different passages of 
DFSCs.  All of the statistical analyses were performed with SAS program version 9.3 (SAS, 
Cary, NC, USA).  Statistical difference was determined at P≤0.05 being significant. 
3.3 RESULTS 
3.3.1 Reduction in DMP1 expression during in vitro culture of DFSCs 
Expression of DMP1 in different passages of DFSCs was determined using real-time RT-
PCR.  The results revealed an overall trend of decreased expression of DMP1 with progression 
of cell passaging (Figure 3.1; Section A).  The expression started to decline at passage 7, and by 
passage 9 there was greater than a 50% reduction in expression as compared to passage 3.  This 
reduction was statistically significant (Figure 3.1; Section A).  
3.3.2 Correlation between DMP1 expression and osteogenesis of DFSCs 
To determine the correlation between DMP1 expression and osteogenic capability of 
DFSCs, different passages of DFSCs were induced for osteogenesis for 2 weeks before being 
stained by Alizarin Red.  Osteogenesis of different passage DFSCs was quantitatively measured 
as shown in Figure 3.1; Section B.  Pearson correlation analysis indicated a strong correlation 
between DMP1 expression and osteogenesis in different passages of DFSCs with a correlation 






Figure 3.1 Correlation between DMP1 expression and osteogenic capability in the different 
passages of DFSCs. (A) DMP1 expression was significantly reduced at P9 as determined by 
real-time RT-PCR. (B) Significant reduction of osteogenic differentiation in the DFSCs at 
passages 7 and 9 determined by Alizarin Red staining measured with Image-Pro Analyzer. (C) 
Pearson correlation analysis showed a strong correlation between DMP1 expression and 
osteogenesis in different passages of DFSCs with correlation coefficient r=0.92503.  * indicates 
significant difference at P≤0.05 (N=4). DFSCs: dental follicle stem cells; DMP1: dentin matrix 







3.3.3 Inhibition of osteogenesis by knockdown of DMP1 expression in DFSCs 
Since expression of DMP1 appeared to correlate to osteogenic potential of DFSCs, it was 
important to determine whether there was a cause and effect relationship between DMP1 
expression and osteogenesis.  In this regard, early passages (P3 and P5) of DFSCs that expressed 
high levels of DMP1 were transfected with DMP1-siRNA.  With real-time RT-PCR, we checked 
the knockdown efficiency and found that about 90% knockdown could be achieved 3 days after 
DMP1-siRNA transfection and 85% knockdown was still seen after 5 days of transfection.  After 
subjecting the transfected DFSCs to osteogenic induction, significant reduction of osteogenesis 
was observed in the DMP1-siRNA transfected cells, whereas no noticeable difference was seen 
in cells transfected with the scrambled siRNA as compared to the mock transfection control 
(Figure 3.2; Section A).  Knockdown of DMP1 also significantly reduced expression of selected 
osteogenic genes in transfected DFSCs when subjected to osteogenesis induction (Figure 3.2; 
Section B).  In particular, the reduction was more than 40% for bone morphogenetic protein 6 
(BMP6) and bone morphogenetic protein 5 (BMP5); the reduction was about 30% for bone 
morphogenetic protein 2 (BMP2), matrix metallopeptidase 13 (MMP13) and runt-related 
transcription factor 2 (RUNX2).  Slight reduction of fms-related tyrosine kinase 1 (FLT1) and 
biglycan (BGN) expression was also detected.  Statistical analysis determined that the reduction 
of the expression of these genes was significant as compared to the untransfected control (Figure 
3.2; Section B). 
3.3.4 Enhancement of osteogenesis of DFSCs by DMP1 protein 
When passage 9 DFSCs that had reduced osteogenesis and expression of DMP1 were 
incubated in the osteogenic medium containing mrDMP1 protein for 14 days, we observed an 
increase of osteogenesis when mrDMP1 was added to the induction medium.  This DMP1 effect 
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was concentration-dependent.  As shown in Figure 3.3, a dramatic increase of osteogenesis was 
seen at concentrations of 200 and 250 ng/ml.  
 
Figure 3.2 Effect of DMP1 knockdown on osteogenesis and osteogenic gene expression.  (A) 
Alizarin Red staining revealed that knockdown of DMP1 expression in early passages of DFSCs 
resulted in a notable reduction of calcium deposition after 14 days of osteogenic induction when 
compared to the mock transfection and scrambled siRNA transfection controls.  (B) Real-time 
RT-PCR determined the decreased RGE of selective osteogenic genes in DFSCs after DMP1 
knockdown as compared to the control after 7 days of osteogenic induction.  * and ** indicate 
significant reduction at P≤0.05 and P≤0.001(N=3), respectively, as compared to the control for 
the given genes.  BGN: biglycan; BMP2: bone morphogenetic protein 2; BMP5: bone 
morphogenetic protein 5; BMP6: bone morphogenetic protein 6; DMP1: dentin matrix protein 1; 
DFSCs: dental follicle stem cells; FLT1: fms-related tyrosine kinase 1; MMP13: matrix 





Figure 3.3 Effect of exogenous DMP1 on osteogenesis of the late passage DFSCs.  Note that 
addition of mrDMP1 to the osteogenic induction medium increased calcium deposition in P9 
DFSCs after 14 days of induction as shown by Alizarin Red staining.  No staining was seen in 
the control without addition of mrDMP1, whereas adding mrDMP1 to the osteogenic medium 
resulted in increased Alizarin Red staining in a concentration-dependent manner.  DFSCs: dental 
follicle stem cells; mrDMP1: mouse recombinant dentin matrix protein 1; P: passage. 
 
3.4 DISCUSSION  
The DF is a loose connective tissue sac consisting of fibroblast-like non-stem cell DFCs 
that are not capable of differentiation, and DFSCs that are capable of osteogenic differentiation 
[1, 2].  In Chapter 2, we showed that DMP1 was highly expressed in the DFSCs, but not 
expressed in DFCs.  We sought to elucidate the function of DMP1 in the DFSCs in this chapter.  
Our results indicate that the high level of expression of DMP1 in the DFSCs is critical for 
maintaining the differentiation potential of DFSCs.  
It has been reported that DMP1 is expressed in differentiated calcium-depositing cells, 
including osteoblasts, osteocytes and odontoblasts [6, 7, 8, 15].  Undifferentiated preosteoblasts 
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also have been shown to express DMP1 [10].  Given that the DFSCs express high levels of 
DMP1 as revealed in this study, it is possible that the population of DFSCs contains osteoblasts 
and other progenitor cells.  However, our previous studies demonstrated that the DFSCs were 
capable of multipotent differentiation into osteoblasts, adipocytes and neurospheres [1, 16].  It is 
unclear whether the DFSCs are composed of different subpopulations of progenitor cells or only 
multipotent stem cells.   Further studies are needed to clarify this and to determine whether the 
DMP1 is expressed in certain subpopulations of cells in the DFSCs.  For example, fluorescence 
activated cell sorting (FACS) may be employed to obtain different cell subpopulations from the 
DFSCs, followed by real-time RT-PCR and western blotting to determine DMP1 expression in 
each subpopulation.   
 It is well known that DMP1 plays an important role for matrix biomineralization of 
bone and dentin.  DMP1 is essential in the maturation of odontoblasts and osteoblasts [11, 12, 
17].  In this study, we determined the strong correlation between DMP1 expression and 
osteogenic capability of DFSCs.  DMP1 expression was reduced in long-term cultured DFSCs, 
and when the DFSCs with reduced DMP1 expression were subjected to osteogenic induction, 
their osteogenic capability was reduced.  DMP1 knockdown study indicated that the DMP1 
expression and osteogenic differentiation was not merely correlation, but there was a cause-and-
effect relationship.  This is supported by our observation in the cell culture experiment where 
addition of mrDMP1 could partially restore osteogenesis in the late passage DFSCs.  Thus, 
together, the results of this study suggest that DMP1 may function to maintain osteogenic 
capability of the DFSCs.   
 DMP1 has been showed to bind to the promoter of dentin sialophosphoprotein (DSPP) 
to regulate the expression of that gene [11].  Given that DMP1 possesses a promoter binding 
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property and can function as a transcription factor [10], it would be interesting to determine 
whether DMP1 can regulate the expression of osteogenic-related genes.  We found that 
knockdown of DMP1 resulted in reduction of the expression of osteogenic-related genes (BMP2, 
BMP5, BMP6 , FLT1, MMP13, RUNX2 and BGN) during osteogenic differentiation of  the 
DFSCs, suggesting that DMP1 is likely involved in up-regulating the expression of these 
osteogenic genes necessary for differentiation of DFSCs.  This observation is supported by  
Narayanan et al., who reported that overexpression of DMP1 in mesenchymal stem cells induces 
the expression of genes involved in early and proliferative stages of mineralization such as 
RUNX2, BMP2, BMP4, ALP, OCN, DMP2, and DSP [18].  Further studies are needed to 
determine whether DMP1 can bind to the promoter and enhancer regions of these osteogenic 
genes via bioinformatics analysis. 
Exogenous DMP1 can exert its effect by entering the cells via endocytosis or by binding 
to its membrane receptors to activate an internal signaling pathway leading to osteogenesis [19, 
20].  Recent studies revealed that αvβ3 integrin is the cell surface receptor of DMP1 [19].  We 
found that adding mrDMP1 to osteogenic induction medium could recover/promote the 
osteogenesis of late passage DFSCs that had reduced osteogenic capability and decreased DMP1 
expression.  This finding confirms that DMP1 can also act as an extracellular factor for 
promoting osteogenesis in the DFSCs.  
In summary, our study shows that DMP1 is highly expressed in the DFSCs derived from 
the DF, but not in the non-stem cell fibroblast-like DFCs of the same origin.  The expression of 
DMP1 was not due to presence of other calcium-depositing cells, such as osteoblasts and 
odontoblasts, in the DFSC population.  This high level expression of DMP1 is likely necessary to 
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maintain the osteogenic differentiation capability of DFSCs.  Moreover, our results indicate that 
DMP1 participates in regulating the expression of osteogenic genes in the DFSCs. 
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CHAPTER 4: ACTIVATION OF THE PROLIFERATION AND 






Stem cells residing in adult tissues are termed adult stem cells (AdSCs).  AdSCs are non-
differentiated cells that play important roles for maintaining tissue integrity in vivo through both 
normal tissue renewal and pathological tissue regeneration [1].  Due to therapeutic potential of 
the AdSCs, extensive research has been attempted to isolate and characterize the AdSCs from 
various tissues including dental tissues (e.g., dental follicle and dental pulp).  Dental stem cells 
have been shown to be an optimal alternative type of stem cells in reconstructive dentistry and 
regeneration of craniofacial defects [2].  Studies have shown that dental follicle stem cells 
(DFSCs) possess typical AdSCs properties of self-renewal, colony formation and multilineage 
differentiation [3, 4], suggesting that DFSCs would be useful for tissue engineering and 
regeneration.   
It is believed that the majority of AdSCs residing in tissues exists in a slow cycling and 
quiescent state under normal physiologic conditions [5, 6].  This quiescent property is one of the 
self-protection mechanisms of AdSCs to prevent the cells from malignant transformation [5, 7].  
However, this quiescent state could be awakened by certain factors, such as tissue injury signals 
released by damaged cells [8, 9].  Once activated, AdSCs can be recruited to sites of injury to 
repair or regenerate the damaged tissue [10]. 
Besides slow cycling, another self-protection mechanism is that stem cells exhibit higher 
stress tolerance than differentiated cells [11].  Recent studies in our laboratory revealed that 
DFSCs express higher levels of certain heat shock proteins (HSPs) than do their non-stem cell 
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counterparts [12].  It is well-known that HSPs can protect cells from stress damage.  Thus, high 
level expression of HSPs would allow DFSCs to endure the stress conditions.  We have shown 
that DFSCs appear to grow more rapidly than their non-stem cell counterparts at a heat-stress 
condition, suggesting that heat-stress could likely serve as a signal to activate stem cells from the 
quiescent state [12].  Thus, we proposed that this stress tolerant differential of stem cells and 
non-stem cells could be explored to develop cell culture conditions for purification and 
proliferation of stem cells. 
Given the above background, our objectives of this study were to answer the following 
questions: (a) What is the optimal temperature for growth of DFSCs? (b) Can heat-stress serves 
as a signal to activate/ stimulate proliferation and differentiation of DFSCs?  (c) What stem cell-
related genes are affected by the heat-stress during proliferation and differentiation?  Addressing 
the questions would help in understanding stem cell biology and developing methods for 
proliferation and differentiation of DFSCs. The results of the research also have significant 
implication on application of DFSCs, as well as other AdSCs. 
4.2 MATERIALS AND METHODS  
4.2.1 Cell cultures 
Sprague Dawley rats were bred to produce pups for isolating DFSCs with a protocol 
reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of 
Louisiana State University (LSU).  Dental follicles (DFs) were surgically isolated from the first 
mandibular molar of rat pups at days 6-7 postnatally.  Followed by trypsinization, the primary 
dental follicle cell suspension was obtained, and then the cell suspension was cultured in stem 
cell growth medium containing α-MEM (Invitrogen, Grand Island, NY, USA) + 20% fetal 
bovine serum (FBS, Atlanta Biologicals, Flowery Branch, GA, USA ) + 1% Penicillin-
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Streptomycin 10,000 u/ml (Invitrogen, Grand Island, NY, USA) [3] to establish the DFSC 
culture.  To establish non-stem cell dental follicle cells (DFCs), the primary cells were cultured 
in fibroblast growth medium [13].  DFCs established under such conditions have been shown to 
contain no stem cells [3].  The cell cultures were maintained at 37ºC and 5% CO2 atmosphere.  
Stem cell medium was changed every 4 days, and the cells were detached with trypsin and 
passed into new flasks at 80-90% confluency.  DFSCs at passages 3-5 were used in this study. 
4.2.2 Cell proliferation assays 




) were seeded in 6-well plates and cultured in 
stem cell growth medium.  The plates were incubated at 37ºC (control), 38ºC, 39ºC, 40ºC and 
41ºC for 1, 3 and 5 days.  Cell proliferation was evaluated by Alamar blue reduction assay [12]. 
For Alamar blue reduction assay, the culture medium was removed and 1 ml of assay medium 
containing α-MEM, 10% FBS and 10% Alamar blue (Invitrogen, Grand Island, NY, USA) was 
added to each well.  After 2 hours of incubation, 100 µl of assay medium was loaded into 96-
well plates and the optical density was read at 570 nm and 595 nm.  Alamar blue reduction was 
calculated using the formula provided by the manufacturer (Invitrogen, Grand Island, NY, USA).  
To confirm the results of Alamar blue reduction assay, a cell counting-based method was 
performed to obtain the number of viable dissociated cells as described in the literature [14].  To 
do that, DFSCs were seeded in T-25 flasks at density of 10
4
cells/flask and cultured for 5 days.  
Cells then were trypsinized and collected by centrifugation.  After re-suspension in 5 ml fresh 
medium, the number of dissociated cells was counted for each treatment using Cellometer
TM
 
Auto T4 cell counter (Nexcelom Bioscience, Lawrence, MA, USA).  The results were reported as 




4.2.3 Osteogenic differentiation    
For assessment of the effect of temperatures on osteogenic capability of DFSCs, cells 
proliferated at 37
o





in osteogenic medium at different temperatures ranging from 37 to 41
o
C.  The osteogenic 
medium consisted of DMEM-LG (Invitrogen, Grand Island, NY, USA), 10% FBS (Atlanta 
Biologicals, Flowery Branch, GA, USA ), 1% Penicillin-Streptomycin 10,000 u/ml (Invitrogen, 
Grand Island, NY, USA) , 50 µg/ml ascorbate-2 phosphate, 10
-5
 mM dexamethasone and 10 mM 
β-glycerophosphate (Sigma-Aldrich, St. Louis, MO, USA).  After 7 and 14 days of induction, 
mineral deposition was evaluated by Alizarin Red staining.  
4.2.4 Gene expression study 
To explore the effect of the elevated temperatures (i.e., heat-stress) on molecular 
characterization of DFSCs, the cells were collected after designated times of incubation in 
various heat-stress temperatures during proliferation and differentiation, respectively.  For 
proliferation, DFSCs were collected after 7 days of incubation in stem cell growth medium.  For 
differentiation, the cells were harvested after 7 and 14 days of osteogenic induction.  We also 
assessed the effect of the heat-stress on expression of marker genes in the non-stem cell DFCs.  
To do that, the DFCs were incubated in the same heat-stress condition as for DFSCs for 7 days 
before they were collected for RNA isolation.      
Total RNA was extracted with RNeasy® Mini kit (Qiagen, Valencia, CA, USA) from the 
collected cells.  Gene expression of selected stem cell markers and osteogenic markers was 
determined using real-time RT-PCR with the primers listed in Table 4.1.  Briefly, about 2 µg 
RNA was reverse-transcribed into 20 µl cDNA using random primers and MLV reverse 
transcriptase (Invitrogen, Grand Island, NY, USA).  SYBR green real-time PCR was conducted  
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Table 4.1 Primer pairs used for real-time RT-PCR in Chapter 4 
 
ALP: alkaline phosphatase; BCRP: breast cancer resistance protein; BGN: biglycan; BMP2: 
bone morphogenetic protein 2; BMP3: bone morphogenetic protein 3; BMP6: bone 
morphogenetic protein 6; COL3A1: Collagen Type III A1; COL9A1: collagen Type IX A1; C-
KIT: receptor tyrosine kinases. 
 
Gene Primer sequence GeneBank reference # 
ALP F: 5´-GACAAGAAGCCCTTCACAGC-3´ 
R: 5´-ACTGGGCCTGGTAGTTGTTG-3´ 
NM_013059.1 
BCRP F: 5´-GTTTGGACTCAAGCACAGCA-3´ 
R: 5´-AATACCGAGGCTGGTGAATG-3´ 
NM_181381.2 
BGN F: 5´-AGAATGGGAGCCTGAGTTTTCT-3´ 
R: 5´-ACCTTGGTGATGTTGTTGGAGT-3´ 
NM_017087.1 
BMP2 F: 5´-CTCAGCGAGTTTGAGTTGAGG-3´ 
R: 5´-GGTACAGGTCGAGCATATAGGG-3´ 
NM_017178.1 
BMP3 F: 5´-TACTACAGTCCCTTCCGTCTCC-3´ 
R: 5´-AAACAACCTAGCCACAGACACA-3´ 
NM_017105.1 
BMP6 F: 5´-CTTACAGGAGCATCAGCACAGA-3´ 
R: 5´-GTCACCACCCACAGATTGCTA-3´ 
NM_013107.1 
COL3A1 F: 5´-GAAAGAATGGGGAGACTGGAC-3´ 
R: 5´-TATGCCTTGTAATCCTTGTGGA-3´ 
NM_032085.1 
COL9A1 F: 5´-TGAGAGTTGTGCAAGAGCATTT-3´ 
R: 5´-ATCTGACCAGGGAAACCATTC-3´ 
NM_001100842.1 






(Table 4.1 continued) 
CTSK: cathepsin K; ESRRB: estrogen-related receptor beta; FLT1: fms-related tyrosine kinase 1; 
RUNX2: runt-related transcription factor 2; SPP1: Secreted phosphoprotein 1; β-actin: beta actin. 
 
with 0.5 µl cDNA for each sample.  Relative gene expression (RGE) was calculated with the 
ΔCT method using temperature of 37
o
C as the control. 
4.2.5 Alkaline phosphatase (ALP) staining 




.  After 7 days of 
incubation at designed temperatures, cells were stained for cell membrane ALP using a Stem 
TAG 
TM
 alkaline phosphatase staining kit (Cell Biolabs, INC, San Diego, CA, USA) according to 
the manufacturer’s protocol.  Briefly, cells were fixed with fixing solution provided by the kit 
and then incubated in staining solution for 20 minutes without exposure to light.  The staining 
Gene Primer sequence GeneBank reference # 
CTSK F: 5´-TCTCACATTCCTTCCTCAACAG-3´ 
R: 5´-GACTCCAGCGTCTATCAGCAC-3´ 
NM_031560.2 
FLT1 F: 5´-ACAGAAGAGGATGAGGGTGTCT-3´ 
R: 5´-ATCAGCTCCAGGTTTGACTTGT-3´ 
NM_019306.1 
ESRRB F: 5´-GTGCCTGAAGGGGATATCAA-3´ 
R: 5´-AGAAACCTGGGATGTGCTTG-3´ 
NM_001008516.2 
RUNX2 F: 5´-TACTTCGTCAGCGTCCTATCAG-3´ 
R: 5´-ATCAGCGTCAACACCATCATT-3´ 
NM_053470.2 
SPP1 F: 5´-TACTACAGTCCCTTCCGTCTCC-3´ 
R: 5´-AAACAACCTAGCCACAGACACA-3´ 
NM_017105.1 





solution was removed and the plates were washed with PBS.  ALP staining was observed with an 
inverted microscope.  Cells cultured at normal temperature (37ºC) were used as the control. 
4.2.6 Statistical analysis  
 Each of the experiments was repeated a minimum of N=3 times.  The treatment effect 
was compared with analysis of variance (ANOVA) using the SAS version 9.3 (SAS, Cary, NC, 
USA).  The means were separated with least significant difference (LSD) at P≤0.05.  
4.3 RESULTS 
4.3.1 Optimal temperature for growth of DFSCs 
Alamar blue reduction assay was conducted to monitor cell proliferation. An increase in 
Alamar blue reduction indicates an increase of cell growth in the culture. Significantly higher 
Alamar blue reduction was seen when cells were incubated at 38 to 40
o
C as compared to the 
37
o
C control during 3 days of incubation (Figure 4.1; Section A).  In contrast, cells incubated at 
41
o
C gave the lowest Alamar blue reduction, which was lower than cells cultured at 37
o
C and 
other heat-stress temperatures (Figure 4.1; Section A).    
Alamar blue is a non-toxic dye used for continuously monitoring cell growth in cultures.  
Its sensitivity reduces once cultures reach certain cell densities.  Thus, a more accurate and labor-
intensive cell-counting based method was used to obtain the mean number of dissociated cells/ml 
after 5 days of incubation as shown in Figure 4.1; Section B.  The number of dissociated cells 
was 2.1 x 10
3
/ml when cells were incubated at 37
o
C (control), whereas a continuous increase in 
the number of cells was observed when cells were cultured at elevated temperatures with a 




C (Figure 4.1; Section B).  Cell number increase 
was statistically significant at 38 to 40
o
C when compared to the 37
o
C control.  In contrast to that 
increase, a significant reduction of cell number was seen when cells were cultured at 41ºC.  
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Thus, the results based on cell-counting and Alamar blue reduction assay suggest that the 





Figure 4.1 Proliferation of DFSCs under different temperatures (37ºC-41ºC).  (A) Proliferation 
was continuously monitored with Alamar blue reduction assay after 1, 3 and 5 days of 
incubation.  (B) Final cell numbers after 5 days of culture were assessed by cell counting. Note 
that a significant increase of cell proliferation was observed at the heat-stress temperatures of 
38ºC-40ºC after 3 and 5 days of incubation as compared to the 37ºC (control), whereas the cell 
number after 5 days of incubation was significantly lower at  41ºC compared to other 
temperatures.  * indicates significant difference at P≤0.05 when compared to the control (37°C). 





4.3.2 Differentiation of DFSCs at elevated temperatures  
Subjecting the DFSCs to osteogenic differentiation at different temperatures, we 
observed that osteogenesis, as shown by Alizarin Red staining, could be occasionally detected 
after as early as 7 days of induction only at 39 and 40
o
C treatments (Figure 4.2; Section A).  
After 14 days of induction, osteogenesis occurred at all treatments, and osteogenesis increased 
coincidentally with the increase of the temperatures from 37 to 40
o
C with the maximum seen at 
39 and 40
o
C (Figure 4.2; Section B).  However, when DFSCs were incubated in 41
o
C for 
osteogenic induction, a complete loss of osteogenesis usually was observed, although reduced 
osteogenesis sometimes was still seen (Figure 4.2; Section C). 
 
Figure 4.2 Effect of temperatures on induction of osteogenic differentiation of DFSCs as 
determined by Alizarin Red staining.  (A) Mineral deposition was detected after 7 days of 
induction only from cells incubated at 39 and 40ºC (arrows).  (B) An increase of staining was 
seen as temperatures elevating from 37ºC-40ºC after 14 days of induction.  (C) When DFSCs 
were subjected to osteogenic differentiation at  41ºC for 14 days, variability  of osteogenesis was 
observed ranging from loss of osteogenic capability to abnormal osteogenesis. DFSCs: dental 




4.3.3 Expression of stem cell-related markers 
DFSCs were collected after 7 days of incubation in stem cell growth medium at different 
temperatures for gene expression analysis.  RGE of selected stem cell markers was determined 
by real-time RT-PCR as shown in Figure 4.3; Section A.  Increased expression of  ALP, BCRP, 
BMP3, COL9A1, C-KIT and ESRRB was observed when cells were cultured at 38ºC-40ºC, as 
compared to the controls  grown at 37ºC.  In general, the increase in gene expression was 
coincident with the increase of temperatures.  Statistical analysis determined that the increase 
was significant for ALP, BCRP, and COL9A1 at 39 and 40ºC as compared to the 37ºC control.  
DFSCs grown in different temperatures were also stained for membrane ALP.  The result 
showed that a great number of cells grown in 38ºC-40ºC stained high level of membrane ALP 
(Figure 4.3; Section C), whereas low ALP staining was observed in DFSCs incubated at 41ºC.   
When DFCs were incubated at elevated temperatures, a slight increase of ALP and BCRP 
was observed with no statistical significance (Figure 4.3; Section B).  The RGE in DFCs was 
generally lower than in DFSCs, except for BMP3.  For example, at 40
o
C treatment, ALP 
increased greater than 90% (i.e., RGE >1.9) in DFSCs, whereas in DFCs the increase was only 
20%.  Decrease of expression of COL9A1 and C-KIT in the DFCs was observed at certain heat-
stress conditions, but statistical differences could not be detected.  Thus, in general, heat-stress 
treatments appeared to cause no significant change of expression of these stem cell marker genes 
in the DFCs.  Interestingly, heat-stress at 40
o
C showed a significant increase of BMP3 
expression in the DFCs (Figure 4.3; Section B), but not in DFSCs (Figure 4.3; Section A).   
For assessment of the expression of osteogenic markers during osteogenic induction, 
DFSCs were collected after 7 and 14 days of osteogenic induction at different temperatures 




































































































































































































































































































































































































































































































































































Figure 4.4 Expression of osteoblast marker genes in the DFSCs subjected to osteogenic 
induction.  RGE was determined by real-time RT-PCR after 7 days of induction (A) and after 14 
days of induction (B).  RGE was calculated from 3 experiments.  The bar (RGE) labeled with * 
indicates significant difference at P≤0.05 as compared to the control (37 ºC).  Note that the 
significantly increased expression of BMP6 and FLT1 was observed in the heat-stress treatments 
compared to the control after 7 days of osteogenic induction.  However, the expression of BMP6 
and FLT1 was reduced for heat-stress treatments after 14 days of induction.  BMP2 : bone 
morphogenetic protein 2; BMP6: bone morphogenetic protein 6; BGN: biglycan; COl3A1: 
Collagen Type III A1; CTSK: cathepsin K; DFSCs: dental follicle stem cells; FLT1: fms-related 
tyrosine kinase 1; RUNX2: runt-related transcription factor 2; RGE: relative gene expression; 
SPP1: Secreted phosphoprotein 1. 
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days of induction, expression of BMP2, COL3A1 and BGN was slightly enhanced at 39ºC and 
40ºC with a maximum of 50% increase as compared to the control.  In contrast, more than a 50% 
increase in expression of BMP6, FLT1, RUNX2 and SPP1 was detected at elevated temperatures 
versus 37
o
C.  Of them, more than a 2-fold increase of RUNX2 and SPP1 was seen in some 
treatments (Figure 4.4; Section A).  Generally, as the temperature increased from 37 to 40
o
C, 
expression of these osteogenic markers also increased with the exception of CTSK.  Statistical 
analysis indicated that increased gene expression was significant at 39 and 40ºC when compared 
to the control (Figure 4.4; Section A).  
Expression of the osteogenic markers was also determined after 14 days of induction at 
different temperatures (Figure 4.4; Section B).  Expression of BMP2, COL3A1, CTSK and BGN 
was still significantly higher in elevated temperature treatments than in the control.  However, no 
significant increase was seen in expression of BMP6 and FLT1 between elevated temperature 
treatments and the 37
o
C control.  A significant decrease of FLT1 expression was observed after 
14 days of induction at 40ºC. 
4.4 DISCUSSION  
DFSCs have been isolated from different species including humans and rats [3, 4], and 
their potential uses in tissue regeneration have been investigated.  Due to the small size and 
limited source of the tissue, isolation of large quantity of the DFSCs is difficult.  Rapid 
expansion of primary isolation to obtain sufficient quantity of such stem cells with high 
differentiation potential is usually necessary and desired for application of such stem cells.  
Evidence from our previous studies has shown that DFSCs are likely more tolerant to heat-stress 
than their non-stem cell counterparts.  We reported that DFSCs grew more rapidly under certain 
heat-stress conditions than at 37
o
C [12].  In this study, we determined that the optimal 
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temperature for in vitro proliferation of DFSCs was 39 to 40
o
C.  Studies have suggested that 
most AdSCs exist in the tissues at quiescent stage [5, 6], and cell injury signals could activate 
quiescent stem cells to start rapid proliferation and differentiation for tissue repair [8].  For 
example, in the case of hepatic diseases, various stem cells are activated and recruited to the 
injury site for liver regeneration [10].  In this study, DFSCs grown in a mild heat-stress condition 
equivalent to common fever resulted in rapid cell proliferation. 
Recent findings suggest that heat-stress could promote neural differentiation of mouse 
embryonal carcinoma stem cells, and that HSPs appear to regulate this differentiation [15].  To 
determine if heat-stress treatments can enhance differentiation capability of DFSCs, DFSCs were 
subjected to osteogenic induction at temperatures ranging from 37ºC-41ºC.  DFSCs from 38ºC -
40
o
C treatments resulted in greater osteogenesis than did the 37
o
C control, indicating that proper 
heat-stress treatments could promote differentiation.  Our previous study revealed that DFSCs 
express higher levels of several HSPs than do their non-stem cell counterparts [12]; however, 
further studies are needed to determine the roles of HSPs in promoting osteogenesis of DFSCs.  
Taken together, the results suggest that the elevated temperature could likely serve as a signal to 
activate the tissue stem cells to undergo proliferation and differentiation.   
 Based on the marker gene expression, the DFSCs had a significantly increased 
expression of the selected markers including ALP, BCRP, COL9A1 and C-KIT after incubation 
at elevated temperatures.  This could be due to an increase of stem cell numbers in the cell 
population and/or enhanced expression of the markers by heat-stress treatments.  Regarding the 
former, it should be kept in mind that the DFSCs population used in this study was 
heterogeneous in that it contained stem cells and non-stem cells.  Because stem cells possess 
greater heat-tolerance and grow more rapidly than non-stem cells in heat-stress conditions, the 
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number of stem cells in this heterogeneous population could be increased after proliferation in 
elevated temperatures [12].  Another possibility is that the heat-stress induced the expression of 
the marker genes.  We grew the non-stem cell dental follicle cells (DFCs) in the elevated 
temperatures and found that heat-stress did not result in a significant change in expression of 
these genes in the DFCs.  Thus, increased expression of the genes should largely come from the 
stem cells in the population.  We speculate that the increased expression of the genes in the 
DFSCs under elevated temperatures could likely enhance the cell’s heat resistant capability, and 
thus allow the DFSCs to endure the heat-stress condition as discussed in the following. 
ALP has been reported as a universal marker for all types of pluripotent stem cells [16, 
17].  Undifferentiated stem cells have elevated levels of ALP on their cell membranes and thus 
membrane ALP staining is used to detect these cells [18].  Enhancement of ALP activity by 
oxidative and heat-stresses has been observed in intestinal epithelial cells and dental pulp cells, 
respectively [19, 20].  When rat pulp cells were subjected to 42
o
C heat-stress for 30 minutes, 
ALP activity was increased in the cells up to 14 days [20]. Our study indicated that ALP 
expression in DFSCs also was enhanced by heat-stress. The role of ALP in protecting stem cells 
from heat-stress is currently unknown.  
BCRP is abundantly expressed in various AdSCs [21] to serve as a detoxification 
mechanism of stem cells [22].  We have shown that DFSCs can express BCRP [3].  It has been 
suggested that BCRP may play a physiological role in survival of stem cells under a hypoxic 
environment [23].  The significant increase of BCRP expression seen in heat-stressed DFSCs 
suggests that BCRP may also play a role in the survival of stem cells under heat-stress 
conditions.   
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C-KIT has been found on the surface of hematopoietic stem cells, as well as in 
mesenchymal stem cells [24, 25].  Binding of stem cell factor (SCF) to C-KIT activates various 
signal transductions which play roles in proliferation and differentiation.  In addition, the SCF/C-
kit pathway functions to protect cells from stress-induced cell damage.  For example, it has been 
suggested that SCF/ C-KIT can activate an anti-apoptotic pathway to promote cell survival [24- 
27].  Because heat-stress can induce apoptosis [28, 29], the increased expression of C-KIT in 
heat-stressed DFSCs may prevent activation of the apoptotic pathway under elevated 
temperatures and thus increase cell survival. 
When DFSCs were subjected to osteogenic induction at different temperatures, 
osteogenesis could occur as early as 7 days in cells incubated at 39 or 40oC, as detected by 
Alizarin Red staining.  No osteogenesis could be seen in the 37
o
C control, suggesting that the 
osteogenic process of DFSCs was accelerated at the elevated temperature.  This was supported 
by the increased expression of osteogenic genes (BMP2, BMP6, COL3A1, FLT1, RUNX2 and 
SPP1) seen in the heat-stressed cells as compared to the control cells after 7 days of induction.   
After 14 days of induction, real-time RT-PCR showed that expression of the osteogenic 
markers (except BMP6 and FLT1) in the elevated temperature treatments remained at a higher 
level than in the control, whereas RGE of BMP6 and FLT1 was greatly reduced in elevated 
temperature treatments.  Given that BMP6 is the earliest of the BMPs to be expressed during 
osteogenic differentiation [30], its high level of expression at day 7 followed by leveling off at 
day 14 seen in this study suggests that BMP6 is likely important for osteogenic differentiation of 
DFSCs at the initiation/early stage. 
FLT1 (also known as vascular endothelial growth factor receptor1--VEGFR1) and FLK1 
(VEGFR2) are the two receptors that bind to VEGF for various biological effects, such as in 
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angiogenesis and hematopoiesis.  In developing mice, metaphyseal blood vessels and trabecular 
bone formation were impaired when some VEGF activity was blocked [31].  When exogenous 
VEGF was applied to mouse femur fractures, blood vessel formation, ossification and new bone 
(callus) maturation were enhanced.  Moreover, inhibition of VEGF dramatically slowed down 
the healing of a tibial cortical bone defect [32].  Thus, VEGF signaling plays important roles not 
only for angiogenesis, but also for osteogenesis.  In that vein, a recent study showed that 
inhibiting both FLT1 and FLK1 activity resulted in decrease of ALP activity during osteoblastic 
differentiation of cultured human periosteal-derived cells.  However, inhibiting FLK1 activity 
did not alter the ALP activity [33], suggesting that Flt1 would be the receptor for VEGF 
signaling in osteogenesis.  In the present study, we observed that FLT1 expression and 
osteogenesis increased at a concurrent manner in the differentiating DFSCs at the initiation stage, 
and its expression was decreased in the DFSCs once differentiation was complete.  This result 
provides additional evidence that VEGF/FLT1 could be the signal pathway for osteogenic 
differentiation.     
In conclusion, this study has demonstrated that elevated temperature could serve as a 
signal to activate stem cells (e.g. DFSCs) from quiescence to undergo proliferation and 
differentiation.  The results are significant in application of stem cells.  From a clinical 
perspective, the results could help to design treatment guidelines in stem cell therapy.  For 
example, prior to transplantation, the stem cells could be incubated at certain elevated 
temperatures to boost their osteogenic capability.  A heat pad may be applied to the injury site 
after a stem cell transplant to promote proliferation and differentiation of the transplanted stem 
cells, and in turn to accelerate the healing process.  However, proper heat (e.g., 39
o
C) and time 
must be carefully considered to avoid thermal damage to tissues when a heat pad is used.  
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The results of this study indicated that culturing DFSCs under mild heat-stress could 
effectively promote proliferation and osteogenic differentiation.  The optimal temperatures to 
grow and differentiate DFSCs appeared to be 39 to 40ºC.  This finding might be used to develop 
a cell culture condition for rapid in vitro expansion of DFSCs for therapeutic applications.  
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CHAPTER 5: EVALUATION OF OSTEOGENIC POTENTIAL OF 




Various factors such as trauma, infection, tumor, and congenital deformities can cause 
craniofacial defects [1].  Conventional approaches for treatment of craniofacial bone defects 
usually require the use of autograft or alloplastic materials.  Both, however, have disadvantages 
that limit their applications in clinics.  For autograft, obtaining autogenous bone requires extra 
surgical procedures with associated co-morbidities [2, 3].  Although alloplastic materials can be 
used for the treatment of such defects with no need of extra surgery, immune rejection and 
infection can occur, resulting in treatment failure.  The concept of harvesting adult stem cells 
(AdSCs), followed by expansion and transplantation for tissue regeneration, has been proposed.  
In that vein, utilization of stem cells for treatment of craniofacial defects has been attempted [4-
8]. 
Stem cells have been isolated from various tissues.  Invasive surgical procedures are 
usually needed to obtain tissues for stem cell isolation.  Since impacted teeth are often extracted 
in dental clinics and discarded, the use of extracted teeth for stem cell isolation does not require 
extra surgery.  Dental follicle (DF), a loose ectomesenchymal tissue surrounding unerupted teeth, 
has been shown to contain progenitor/stem cells.  Thus, dental follicle stem cells (DFSCs) have 
been isolated and tested for stem cell properties [9-11].  DFSCs possess strong osteogenic 
capability to differentiate toward the osteoblast lineage [12, Chapter 2], which makes them 
suitable for repair of skeletal defects.  In addition, since the DF is derived from the neural crest, 
the same origin of craniofacial tissues, it may be preferential to utilize DFSCs for treatment of 
defects in this region.  
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Previous studies have attempted to evaluate the hard-tissue forming potential of DFSCs 
in vivo.  Subcutaneous transplantation of bovine [13] and human DFSCs [14] mixed with 
hydroxyapatite (HA) ceramics showed formation of mineralized structure on the border of the 
HA.  Two other studies have investigated DFSCs for bone regeneration in critical-size defects 
created in the calvarium of immune-deficient rats.  The first study demonstrated the 
differentiation potential of porcine DFSCs into osteogenic lineage cells [15].  Similar results 
were observed from an independent study showing the in vivo bone formation potential of human 
DFSCs [16].  Both studies were done by transplanting DFSC pellets without loading cells into 
scaffolds.  However, scaffolds are important components for tissue engineering because they 
mimic the extracellular matrix and provide a three-dimensional structure for cell attachment and 
vascularization [17].  In particular scaffolds are required for regeneration of large-size defects.  
In attempts to utilize AdSCs for regeneration of skeletal defects, both undifferentiated [4, 5] and 
osteo-induced stem cells [18] have been used.  Hence, it would be beneficial to compare bone 
regeneration capability between undifferentiated and osteoinduced stem cells.  
In the current study, we evaluated bone regeneration potential of DFSCs in rat calvarial 
critical-size defects using immunocompetent rats.  DFSCs isolated from littermates were seeded 
into polycaprolactone (PCL) or polycaprolactone plus hydroxyapatite (PCL-HA).  Prior to 
transplantation, we examined DFSC viability and attachment in interaction with selected 
scaffolds in vitro.  Next, bone regeneration potential of both undifferentiated and osteo-induced 






5.2 MATERIALS AND METHODS  
5.2.1 Animals  
All animal experimental protocols were approved by the Institutional Animal Care and 
Use Committee (IACUC) of Louisiana State University (LSU).  Immunocompetent Sprague 
Dawley (SD) rats were bred in the vivarium of the Department of Laboratory Medicine, School 
of Veterinary Medicine, LSU to produce postnatal pups.  For each litter, female rat pups at 
postnatal day 6 were used for the isolation of DFs, and male pups were kept with their mothers 
until they were weaned at 5 weeks old.  Then each of the 3 males was caged separately until 5 
months old for surgical and stem cell transplantation procedures. 
5.2.2 Establishment of DFSC cultures  
DFSCs were established as described in Chapter 2 (Section 2.2.1).  Four different DFSC 
cultures were established from four different litters.  They were propagated until passage 3 (P3).  
Their osteogenic capability was evaluated by induction for differentiation, and calcium 
deposition was determined using Alizarin Red staining as described in Section 2.2.2.  Then cells 
were transferred to liquid nitrogen for long-term storage.  Cells were recovered from 
cryopreservation when the littermates of the donors reached the designated age for 
transplantation.  
5.2.3 Scaffold preparation and cell seeding 
PCL (100% polycaprolactone) and PCL-HA (75% polycaprolactone and 25% 
hydroxyapatite) were prepared by dissolving in dioxane (Sigma-Aldrich, St. Louis, MO, USA). 
Briefly, two 10 ml solutions were prepared by adding 0.8 g of PCL (100% PCL) or 0.6 g PCL 
and 0.2 g HA (75% PCL: 25% HA) in a glass vial.  The solutions were heated to 120°C and 
mixed until the polymer dissolved.  Next the solutions were poured into polydimethylsiloxane 
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(PDMS) templates and immediately incubated at -20°C for 24 hours, followed by freeze-drying 
at -80°C for 48 hours.  The scaffolds had a pore size of 200-300 µm.  Two different sizes of 
scaffolds were used in this study.  The scaffolds with a diameter of 10 mm and thickness of 5 
mm were used for in vitro experiments, and the scaffolds with a diameter of 5 mm and thickness 
of 0.5 mm were used for in vivo transplantation.  Prior to cell seeding, the scaffolds were 
sterilized with ethylene oxide. 
A total of 10
5 
cells were seeded into each scaffold using the following procedures: Cells 
were suspended in 100 µl stem cell growth medium.  Half of the cells were pipetted into the top 
surface of the scaffold.  After 20 minutes incubation, the scaffolds were flipped, and the rest of 
the cells were pipetted into the other surface of the scaffold followed by incubation for another 
20 minutes.  This incubation period allowed the cells to penetrate into the porous scaffolds.  Cell-
scaffold constructs were then incubated in either stem cell growth medium or osteogenic 
induction medium for the designated time according to different experimental purposes.  
5.2.4 Evaluation of cell attachment loaded into scaffolds  
Cell–scaffold constructs were placed in 48-well plates and incubated in 2 ml stem cell 
growth medium consisting of α-MEM (Invitrogen, Grand Island, NY, USA) + 20% FBS (Atlanta 
Biologicals, Flowery Branch, GA, USA) at 37ºC and 5% CO2.  After 3 days of incubation, the 
constructs were sectioned and fixed with 2% paraformaldehyde and 1.25% glutaraldehyde in a 
0.1 M sodium carbonate (CAC) buffer, pH 7.4 for 1 hour.  Next they were post-fixed in 1% 
osmium tetroxide in 0.1 M CAC buffer for another 1 hour, followed by dehydrating through an 
ethanol series (30%-100%) and drying in a CO2 critical point dryer.  The samples were then 
coated with gold and subjected to scanning electron microscopy (SEM, FEI Quanta 200 ESEM, 
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Hillsboro, Oregon, USA) for examination of cell attachment.  Scaffolds without cells but 
cultured and processed under the same conditions were also examined by SEM as controls. 
5.2.5 Assessment of cell viability loaded into scaffolds 
Cell–scaffold constructs were placed in 48-well plates and incubated in 2 ml stem cell 
growth medium.  PCL and PCL-HA scaffolds without DFSCs were incubated in stem cell 
growth medium and served as negative controls.  Cell viability was evaluated after 1 and 3 days 
of incubation using Alamar blue reduction assay [19].  Briefly, the culture medium was removed 
and replaced with 1 ml of assay medium consisting of α-MEM, 10% FBS and 10% Alamar blue 
(Invitrogen, Grand Island, NY, USA).  After 2 hours of incubation, 100 µl of assay medium was 
loaded into 96-well plates and the optical density was read at 570 nm and 595 nm.  The Alamar 
blue reduction was calculated using manufacturer’s protocol.  
5.2.6 In vivo transplantation of DFSCs 
SD male rats at an age of 5 months with an average body weight of 415 g were used for 
in vivo DFSC transplantation study.  Surgical procedures are illustrated in Figure 5.1.  Prior to 
surgery, the animals were anaesthetized using isoflurane inhalation (Vet one, Boise, ID, USA).  
Animals were placed on a hot water blanket during the operation to prevent hypothermia.  Skin 
around the incision area on parietal bone was shaved after disinfection with Povidone-iodine 5% 
(Purdue Pharma, Stamford, CT, USA).  An incision was made with a surgical blade from the 
nasofrontal area to the anterior area of the occipital protuberance.  Then two 5mm-diameter full 
thickness defects were created around the sagittal suture with a trephine bur (XEMAX, Napa, 
CA, USA) and a low speed dental drill under constant irrigation with sterile saline.  The 
operation was done carefully to avoid injuring the dura mater or underlying blood vessels and 




Figure 5.1 Surgical procedures for transplantation of DFSCs to treat critical-size defects on rat 
calvarial bone.  (A) Experimental rat was anaesthetized using isoflurane inhalation.  (B) Skin in 
the incision area was shaved and disinfected with iodopovidone solution.  (C) A midline incision 
was created from the nasofrontal area to the anterior area of the occipital protuberance.  (D) Two 
5mm full thickness defects were created using trephine bur.  (E) Implants were placed into the 
defects.  (F) The scalp was closed using Michael clips. 
 
medium and then inserted into the defects.  In each litter (cohort) experimental animals were 
randomly assigned to the treatment groups (Table 5.1).  Two types of DFSCs have been used for 
transplantation (Table 5.1).  DFSCs refer to undifferentiated DFSCs, and iDFSCs refer to the 
DFSCs subjected to osteo-induction for 7 days prior to transplantation.  After transplantation, the 
scalp was closed using Michael clips.  Following the surgery, the animals were placed in a warm 
and soft-bedded plastic cage for recovery.  An injection of buprenorphine ( Reckitt Benckiser 
Healthcare Ltd, Hull, UK) 0.05 mg/kg was administrated every 12 hours for 3 days post-
operation as an analgesia.  Endroflaxacin (Bayer, Shawnee Mission, Kansas, USA) was added to 
their drinking water to prevent infection for 7 days.  In each cohort, half of the animals (4 rats) 
were sacrificed after 4 weeks post-operatively, and the other half were sacrificed after 8 weeks.  
To collect the samples, the animals were euthanized using CO2 asphyxiation followed by 
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cervical dislocation or decapitation.  Skulls were harvested surgically, and skins were removed 
completely from the skulls.  The skulls were fixed in 10% Neutral-buffered formalin (Sigma-
Aldrich, St. Louis, MO, USA) for further analysis or examination to determine the treatment 
effects. 
Table 5.1 Treatments for in vivo transplantation  
Treatment Groups* Description 
Empty 
 
For spontaneous healing as the negative control 
PCL only 
Scaffolds without cells were incubated for 3 days in 




PCL + DFSCs 
The cell–scaffold constructs were incubated in stem 
cell growth medium for 3 days prior to transplantation. 
PCL-HA + DFSCs 
 
 
PCL + iDFSCs The cell–scaffold constructs were incubated in stem 
cell growth medium for 3 days followed by 7 days 
induction in osteogenic medium prior to 
transplantation. 
PCL-HA + iDFSCs 
DFSCs: dental follicle stem cells; iDFSCs: osteo-induced dental follicle stem cells; PCL: 
polycaprolactone; PCL-HA: polycaprolactone plus hydroxyapatite. 
*In each cohort (N=4), two animals were used for each treatment group. One animal was 
sacrificed at 4 weeks post-transplantation, and the other was sacrificed after 8 weeks.  
5.2.7 Evaluation of bone regeneration 
The assessment of bone regeneration was done with micro-CT and histological analysis.  
First, harvested skulls were assessed for new bone formation using a micro-CT imaging system 
(Skyscan 1074, Micro photonics, Inc., Allentown, PA, USA) at the Department of Physics and 
Astronomy, LSU.  Samples were mounted on a rotating stage.  The following parameters were 
used for examination of all samples: X-ray voltage of 40 kVp, current of 1000 µA, and exposure 
time of 550 milliseconds for each of the 360 rotational steps.  From the micro-CT data, two-
dimensional images were reconstructed using NRecon, version 1.6.9.4 (Bruker microCT, 
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Kontich, Belgium).  Next, three-dimensional images were made using CTvox, version 2.6.0 
(Bruker microCT, Kontich, Belgium).  Following image intensity modification, quantitative 
analysis of new bone formation was performed using Matlab 2013a software (MathWorks, 
Natick, MA, USA).  The percentage of newly regenerated bone was calculated from the fraction 
of the number of voxels of new bone over the number of voxels of the entire defect.  Procedures 
for micro-CT data analysis are illustrated in Figure 5.2. 
  Following micro-CT scanning, skulls were trimmed using bone cutting forceps and 
transferred to fixation solution (10% Neutral-buffered formalin) for 7 days.  Samples were then 
decalcified with Cal-Ex™ Decalcifier (Fisher Scientific, Pittsburgh, PA, USA) for 14 days.  
Each defect sample was embedded with paraffin.  Five µm serial sections were prepared parallel 
to the sagittal plane.  Sections were mounted on Sperfrost plus
®
 slides (Fisher Scientific, 
Pittsburgh, PA, USA).  They were then deparaffinized in xylene and rehydrated in 95 and 75% 
ethanol.  Next, the slides with odd numbers were stained with Hematoxylin and Eosin (H & E) 
while even-number slides were stained with Masson Trichrome.  For H & E staining, slides were 
stained in Hematoxylin solution (0.5% in distilled water) for 20 minutes followed by 1 minute of 
staining in Eosin (0.25% in 80% ethanol).  For Masson Trichrome staining, sections were first 
stained in Weigert's iron Hematoxylin working solution for 10 minutes, and then stained in 
Biebrich Scarlet-Acid Fuchsin for 2 minutes and Aniline Blue Solution for another 2 minutes.  
After staining, sections were covered with mounting medium and cover slipped.  Digital images 
from stained sections were taken with an optical microscope (Olympus BX48, Center Valley, 







Figure 5.2 Schematic illustrations of the procedures for micro-CT analysis of bone regeneration 
after transplantation of DFSCs to the rat calvarial defects.  (A) Micro-CT scanning of rat skull by 
Skyscan 1074.  (B) Construction of 2D slices by NRecon software.  (C) Construction of a 3D 
image by CTvox software.  (D) Image intensity modification.  (E) Bone and defect segmentation.  
(F) Quantitative analysis of new bone formation using Matlab 2013a. 2D: two-dimensional; 3D: 
three-dimensional; CT: computed tomography. 
 
5.2.8 Statistical analysis 
Statistical analyses were performed using SAS program version 9.3 (SAS, Cary, NC, 
USA).  Analysis of variance (ANOVA) and least significant difference (LSD) were used for 




5.3 RESULTS  
5.3.1 Evaluation of osteogenic capability of established DFSCs 
Four different DFSC cultures established from 4 different litters were used in this study.  
The osteogenic capability of DFSC cultures was verified at P3 by in vitro osteogenic induction 
for 14 days.  Following induction, calcium deposition was visualized using Alizarin Red 
staining.  Robust staining was observed in all cultures, indicating that they possessed strong 
osteogenic differentiation capability (Figure 5.3) and could be used for in vivo transplantation. 
 
 
Figure 5.3 In vitro evaluation of osteogenesis of DFSC cultures.  Note that all four DFSC 
cultures established from different litters possessed strong osteogenic capability at passage 3 
after 2 weeks of induction as shown by Alizarin Red staining.  DFSC: dental follicle stem cell.  
 
5.3.2 Evaluation of DFSC attachment loaded into PCL and PCL-HA scaffolds   
DFSCs, as well as other mesenchymal stem cells, are adherent cells.  Therefore, cell 
attachment to the culture surface is required before they can grow and differentiate.  We 
examined cell attachment by SEM at day 3 after loading DFSCs into scaffolds.  SEM 
micrographs showing cell attachment at different magnifications (500x-3000x) are presented in 
Figure 5.4.  Attachment and infiltration of DFSCs in the porous structure of both scaffolds 
(Figure 5.4; Sections D-F and J-L) were observed, as compared to the control scaffolds without 

































































































































































































































































































































































































































5.3.3 Assessment of DFSC viability/proliferation loaded into PCL and PCL-HA scaffolds 
 
Since induction of differentiation is generally associated with growth arrest, we evaluated 
the cell growth on the scaffold prior to osteogenic induction.  In this regard, the cell viability 
assay was performed during the culture in stem cell growth medium.  Alamar blue reduction 
assay was conducted at days 1 and 3 after cell seeding into PCL and PCL-HA scaffolds.  
Scaffolds without stem cells served as negative control.  Significant increase of Alamar blue 
reduction was seen at day 3 as compared to day 1 in both scaffolds, indicating that DFSCs could 
survive and proliferate in the scaffolds (Figure 5.5).  There was no statistical difference between 
PCL and PCL-HA in Alamar blue reduction assay within given days, suggesting that DFSCs 
proliferate in a similar manner in both scaffolds. 
 
Figure 5.5 Assessment of DFSC viability loaded into PCL and PCL-HA with Alamar blue assay.  
Note that a significant increase of Alamar blue reduction (Mean ± SE) was observed at day 3 
compared to day 1.  For a given day, no difference was seen between PCL and PCL-HA. * 
indicates significant difference at P≤0.05 (N=4). DFSCs: dental follicle stem cells; PCL: 




5.3.4 Micro-CT analysis of bone regeneration after transplantation of DFSCs 
To assess bone regeneration, micro-CT scans were performed at weeks 4 and 8 post-
transplantation.  A representative case from each treatment group is shown in Figure 5.6 (N=4).  
At week 4 post-surgery, micro-CT scanning revealed a complete lack of bone regeneration 
among the defects in all treatment groups (Figure 5.6; Sections A-G).  Scans at week 8 showed 
no bone formation in the negative control (empty defect without cells) (Figure 5.6; Section H).  
Similarly, defects treated with scaffolds only (PCL or PCL-HA) showed no bone regeneration 
(Figure 5.6; Sections I and J).  In comparison, small areas of bone formation were seen in defects 
treated with either PCL-HA plus DFSCs (Figure 5.6; Section M), or PCL-HA plus iDFSCs 
(Figure 5.6; Section N).  However, in the defects treated with PCL plus DFSCs (Figure 5.6; 
Section K) or PCL plus iDFSCs (Figure 5.6; Section L), new bone formation filled almost half of 
the defects. 
Quantitative bone formation was acquired by micro-CT images.  Defects treated with 
PCL plus DFSCs or PCL plus iDFSCs showed a significant increase in the percentage of bone 
healing with 48.9% ± 8.7 and 51.33% ± 2.9 bone regeneration, respectively (Table 5.2 ) as 
compared to the control (0.00%).  The osteogenic induced DFSCs (iDFSCs) gave slightly higher 
bone regeneration than did the DFSCs without induction; however, no significant difference was 
observed (Table 5.2).  Defects treated with PCL-HA plus DFSCs or PCL-HA plus iDFSCs 
resulted in approximately 5% and 3% bone recovery, respectively, over the 8 weeks, which was 






















































































































































































































































































































































































































































































































































































Table 5.2 Percentages of new bone formation in different treatment groups at week 8  post-
transplantation as determined by micro-CT (N=4)  
Treatment Groups New Bone Formation (%) 
Empty 0.00 ± 0.00   
PCL only 0.00 ± 0.00   
PCL-HA only 0.00 ± 0.00   
PCL + DFSCs 48.9 ± 8.7    * 
PCL + iDFSCs 51.33 ± 2.9  * 
PCL-HA + DFSCs 5.01 ± 0.7     
PCL-HA + iDFSCs 2.61 ± 1.1     
DFSCs: dental follicle stem cells; iDFSCs: osteo-induced dental follicle stems cells;  
PCL: polycaprolactone; PCL-HA: polycaprolactone plus hydroxyapatite. * indicates significant 
difference at P≤0.05 when compared to the controls (empty and scaffolds only). 
5.3.5 Histological examination of bone regeneration after transplantation of DFSCs 
Since radiological evaluation shows only mineralization, it is necessary to evaluate bone 
healing by histological examination of bone structure.  Representative slides are shown in 
Figures 5.7 and 5.8 (N=4).  No bone regeneration was observed in all treatment groups at week 4 
after transplantation (Figure 5.7; Sections A-G).  Defects at this time were filled with fibrous 
tissues as seen in Figure 5.7; Sections H-N.  Histological examination of week 8 specimens 
showed absence of bone regeneration in the empty control defect (Figure 5.8; Sections A and H), 
as well as in the defects treated with scaffolds only (Figure 5.8; Sections B, C, I and J).  A small 
layer of osteoid was observed in the defects treated with PCL-HA plus DFSCs (Figure 5.8; 
Sections F, M and Q), or PCL-HA plus iDFSCs (Figure 5.8; Sections G, N and R).  In 
comparison, substantial bone formation was observed in the defects treated with PCL plus 
DFSCs (Figure 5.8; Sections D, K and O) or PCL plus iDFSCs (Figure 5.8; Sections E, L and P).  
Formation of woven bone could be seen in those groups at higher magnification (Figure 5.8; 
Sections O and P).  The appearance of new bone formation was similar to what was expected in 
intramembranous ossification.  The bone formation was confirmed by Masson Trichrome 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(Figure 5.8 continued) 
 
5.4 DISCUSSION  
Utilization of dental stem cells, such as DFSCs, has raised interest in the field of 
regenerative medicine. The advantages of these cells are that they can be isolated from extracted 
impacted teeth that are normally discarded as medical wastes during the course of dental 
treatment [20].  Experimental data have demonstrated multipotential differentiation of DFSCs [9-
11].  Particularly, their strong osteogenic capability makes them an attractive type of AdSCs for 
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repairing bone defects, and in vivo transplantation of DFSCs has been attempted.  In early 
studies, DFSCs were mixed with ceramic phosphate and then transplanted subcutaneously.  Bone 
formation was seen after transplanting the DFSCs, indicating the in vivo bone-forming capacity 
of these cells [13, 14].  Recent studies reported the success of transplanting DFSC pellets to heal 
calvarial critical-size defects in immunocompromised rats [15, 16].  This study sought to extend 
our knowledge regarding the potential application of DFSCs for treatment of skeletal defects.  
Successful bone regeneration was achieved for treatment of calvarial critical-size defects of 
immunocompetent rats after transplanting DFSCs loaded into scaffolds.  
Studies have suggested that scaffold is essential for supporting a three-dimensional 
structure for cell attachment and vascularization [17], particularly in treatment of large defects. 
We tested two types of scaffolds, PCL and PCL-HA for loading DFSCs.  Although DFSCs can 
attach and proliferate in both scaffolds, PCL appears to be remarkably better than PCL-HA for 
DFSCs differentiation, resulting in greater bone regeneration.  HA has been added to a variety of 
scaffolds as an osteioinductive material [4, 5, 21].  It has been shown that addition of HA to the 
scaffolds increases cell attachment and differentiation [22].  HA at percentage of 25%-30% has 
been used in previous studies [5, 23].  In this study, PCL-HA scaffold contained 25% of HA; 
however, we did not observe any beneficial effect in bone regeneration when 25% HA was used 
in the scaffold.  It is likely that the ratio of HA in the scaffold construct should be adjusted 
properly for seeding different types of AdSCs.  
This study revealed that no visible bone regeneration was seen at 4 weeks after 
transplantation of rat DFSCs to critical-size defects, and it took as long as 8 weeks to see the 
healing effect.  Studies using other types of AdSCs, including adipose-derived stem cells (ASCs) 
and bone marrow stem cells (BMSCs), showed the bone healing at 4 weeks post-transplantation 
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[4,5].  Cowan et al., reported 10% and 40% bone formation at 4 weeks after transplantation of 
mouse ASCs and BMSCs, respectively [4].  They observed that the regenerated bone filled 
almost half of the defects at 8 weeks, which is similar to our observation.  However, in a human 
ASC transplantation study, almost complete healing of the defects could be achieved by 8 weeks 
[5].  The bone regeneration seen in our study was generally slower than the AdSC transplantation 
studies reported by others.  This could be due to the following reasons: (A) AdSCs from different 
tissues and different species were transplanted; (B) immunocompromised animals were used in 
the reported study, and immunocompetent animals were used in our study.  Although we did not 
observe any inflammatory reaction in our transplantation experiments, unnoticeable immune 
response might exist after transplantation, causing the delay of the healing process.   
  In the current study, we evaluated bone regeneration of DFSCs without treating cells 
with any growth factors.  Various cytokines and growth factors, such as bone morphogenetic 
proteins (BMPs) and insulin-like growth factor-1 (IGF-1), are known to enhance osteogenic 
repair of AdSCs [5, 24, 25].  Our laboratory has shown that bone morphogenetic protein 6 
(BMP6) and dentin matrix protein 1(DMP1) can enhance the osteogenic capability of DFSCs in 
vitro [12, Chapter 3].  It would be interesting to determine whether addition of these growth 
factors to scaffolds can accelerate the bone regeneration from DFSCs.  In addition, we revealed 
that appropriate stressors, such as heat-stress treatments, can activate DFSCs to proliferate and 
differentiate in vitro (Chapter 4).  Future study should examine if incubation of DFSCs at certain 
elevated temperatures, prior to transplantation, may boost their osteogenic capability in vivo. 
There is a controversy within the literature regarding the necessity of pre-differentiation 
of AdSCs prior to transplantation [5, 19, 26].  This study determined that pre-induction of 
DFSCs slightly enhanced bone formation; however, there was no significant difference between 
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them.  This suggests that pre-induction of DFSCs may not be necessary prior to transplantation.  
This would be beneficial to the patient, since it reduces the overall treatment time. 
Several studies have demonstrated that transplanted cells not only contribute to new bone 
formation, but they can also release the signals to recruit the host’s own stem cells to the defect 
site for tissue regeneration [27].  It is unclear whether the bone regeneration seen in this study 
resulted completely from the transplanted DFSCs, or the host’s own stem cells also contributed 
to the bone regeneration.  To clarify this, DFSCs labeled with a reporter gene, such as GFP 
transgenic rat, can be transplanted for tracking the regeneration.  In this study, because DFSCs 
isolated from female pups were transplanted into adult male rats, it is possible to determine the 
contributions of the transplanted cells versus host cells to bone formation through sex 
chromosome detection [4].  
In conclusion, this study demonstrated that DFSCs are a promising cell type for repair of 
craniofacial defects. Our data suggest that DFSCs, without prior induction, can be directly 
transplanted into craniofacial defects for bone repair in clinics. In addition, PCL appears to be a 
suitable scaffold material for seeding DFSCs for bone regeneration in repairing craniofacial 
defects.   
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CHAPTER 6: CONCLUDING REMARKS 
6.1 SUMMARY OF FINDINGS AND SIGNIFICANCE OF THE RESEARCH 
Utilization of stem cells for treatment of diseased and damaged tissues represents a novel 
approach in regenerative medicine.  Chapter 1 of this dissertation summarizes the basic 
knowledge of stem cells, characteristics of dental stem cells, and their potential applications in 
tissue regeneration.  Particular emphasis has been given to the dental follicle stem cells (DFSCs). 
One of the advantages of DFSCs is that they can be isolated from extracted impacted teeth, 
which are normally discarded as medical waste during the course of dental treatment, while 
isolation of other tissue stem cells usually requires extra invasive procedures.  This dissertation 
focuses on the evaluation of in vitro and in vivo osteogenic capability of DFSCs, which would 
provide important information toward the clinical applications of DFSCs for regeneration of 
bone defects. 
 In Chapter 2, we demonstrated the differentiation of DFSCs toward calcium-depositing 
cells.  Further examination of marker gene expression revealed that the DFSCs primarily 
differentiated toward the osteoblast lineage under our current induction conditions.  However, 
similar to other adult stem cells (AdSCs) [1, 2], such osteogenic capability during in vitro 
expansion was reduced.  Maximal osteogenesis appeared at passage 3 (P3) to passage 5 (P5).  
Thus, for in vivo transplantation of DFSCs, P3 to P5 cells should be used.  Studies in Chapter 2 
also revealed that DFSCs express high levels of stem cell-related genes, including receptor 
tyrosine kinases (C-KIT), neurogenic locus notch homolog protein 1 (NOTCH1), and dentin 
matrix protein 1 (DMP1) as compared to the non-stem dental follicle cells (DFCs) of the same 
origin.  These genes may serve as additional molecular markers for identification of DFSCs.  
Among the stem cell-related genes identified in Chapter 2, DMP1 showed a maximal differential 
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expression in DFSCs than in non-stem cell DFCs.  Given that DMP1 has been reported to 
function as a nucleator for hydroxyapatite maturation as well as transcriptional factor [3-5], in 
Chapter 3, we further evaluated the role of DMP1 in regulating the osteogenic differentiation of 
DFSCs.  We found that this high level expression of DMP1 is likely necessary to maintain the 
osteogenic differentiation capability of DFSCs.  Moreover, our results indicate that DMP1 
regulates expression of other osteogenic genes in the DFSCs, and DMP1 can be added to the 
osteogenic induction medium to improve osteogenesis of long-term cultured DFSCs. 
AdSCs are known to be maintained in a slow cycling and quiescent state under normal 
physiological conditions [6, 7].  Certain factors such as cell injury signals can activate the 
quiescent stem cells to carry out their repairing role when needed [8, 9].  We attempted to use 
heat-stress to activate DFSCs; the results are reported in Chapter 4.  Our experiments showed 
that under heat-stress conditions (39°C-40°C), DFSCs increased proliferation, osteogenic 
differentiation, and expression of stem cell-related marker genes.  The results are significant in 
the application of DFSCs: (a) DFSCs may be cultured in an elevated temperature for rapid in 
vitro expansion prior to transplantation, and (b) DFSCs could be incubated at elevated 
temperatures to boost their osteogenic capability for transplantation. 
One of the ultimate goals of stem cell studies is to use them for repairing tissue damage 
or defects via tissue regeneration.  To explore the use of DFSCs for bone regeneration, DFSCs 
were seeded into scaffolds and transplanted into the calvarial defects of rats.  The results are 
reported in Chapter 5.  Our study indicates that pre-induction of DFSCs for osteogenesis is not 
necessary prior to transplantation.  The synthetic polymer PCL appears to be a suitable scaffold 
for seeding DFSCs.  The successful in vivo bone regeneration from DFSCs in immunocompetent 
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rats shown in this study is an important step toward the establishment of protocols for clinical 
applications of DFSCs.  
6.2 FUTURE STUDIES 
This dissertation focuses on osteogenic differentiation and bone regeneration capability 
of DFSCs.  Approximately 50% of the bone regeneration of critical-size defects was achieved 
after transplanting DFSCs-PCL scaffold at 8 weeks post-transplantation (Chapter 5).  It would be 
necessary to determine whether transplantation of DFSCs can result in full recovery of the 
defects, and the time needed for such recovery.  Various cytokines and growth factors, such as 
bone morphogenetic proteins (BMPs) and insulin-like growth factor-1 (IGF-1) are known to 
enhance osteogenic regeneration of AdSCs [10, 11].  We have shown that the growth factors, 
such as bone morphogenetic protein 6 (BMP6) and dentin matrix protein 1(DMP1), can enhance 
the osteogenic capability of DFSCs [12, Chapter 3].  It would be interesting to determine 
whether coating scaffolds with these growth factors can accelerate healing of skeletal defects, 
particularly in large-size defects in stem cell based therapies.  As shown in the Chapter 4, 
stressors, such as heat-stress treatments (38–40 °C), could activate DFSCs proliferation and 
differentiation in vitro (Chapter 4).  It would be valuable to determine whether incubation of 
DFSCs at certain elevated temperatures, prior to transplantation, may boost their osteogenic 
capability in vivo.  
Due to the small size of the DFs, limited quantities of the DFSCs can be obtained from a 
single tooth.  This dissertation demonstrates that in vitro expansion of DFSCs at high passages 
results in reduction of their osteogenic capability (Chapter 2).  Development of novel culture 
techniques to maintain differentiation potential during expansion of DFSCs would facilitate in 
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obtaining sufficient high-potential cells for regeneration of large defects.  This would be one 
important area in future studies. 
For human therapies, DFSCs from the same patient for autogenous transplantation may 
not be always available.  Although this research suggests that the DFSCs from the siblings can 
be used safely for allogeneic transplantation without activation of a notable immune response in 
rats, the results may not be readily extrapolated to human therapies because genetic background 
of humans is much more complicated than the rat colonies used in this study.  HLA matching is 
necessary for safe transplantation of sibling DFSCs in humans; however, our results imply that 
transplantation of the DFSCs from siblings is expected to have a much lower chance of immune 
response/rejection.   
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